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Well recognized for its role as the energy currency of cells, ATP plays an altogether different 
role in the mammalian vascular system. Erythrocyte-derived extracellular ATP is fast gaining 
recognition as a vital vasodilator in blood; stimulating a rapid widening of blood vessels when 
released into the circulation. Currently, the primary technique employed to determine the 
concentration of ATP released from erythrocytes is the luciferin-luciferase chemiluminescent 
assay, which is both robust in signal and specific for ATP. However, the assay is subject to 
interferences inherent to working with erythrocytes, such as the presence of hemoglobin, which 
filters the emitted chemiluminescence signal.  
At the outset, the current work examined the luciferin-luciferase chemiluminescent assay in the 
microplate format and evaluated the parameters necessary to determine ATP in suspensions of 
intact erythrocytes. Based on the methodological considerations which arose from the 
examination of the assay, the concentration of ATP in suspensions of intact erythrocytes was 
compared to that of their supernatants. It was determined that the ATP released into the 
supernatants of erythrocyte suspensions represents but a fraction of the ATP which is 
externalized and accessible for enzymatic reactions. Known stimuli of ATP release, including 
CO2 and hypo-osmotic stress,  were also used to compare the sensitivity of erythrocytes 
obtained from humans to those from rats, a common pharmacological model organism: human 
erythrocytes proved to be more sensitive to stimuli than rat erythrocytes.  
Ultimately, a method for measuring ATP in suspensions of intact erythrocytes was developed, 
and the possibility of two modes of erythrocyte release was discovered. The erythrocyte has 
long been held as a sensor within the vasculature, and this work underscores the growing 
importance being placed on the erythrocyte’s role as an effector through the regulation of the 
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1. Chapter 1. Introduction  
1.1. Erythrocyte ATP and vasodilation 
 
Erythrocytes, of which there are roughly 5 million per microlitre of whole blood (1), 
are non-nucleated biconcave discs whose major function is to ensure the supply of 
oxygen and nutrients to cells and tissues as well as the removal of carbon dioxide 
(CO2) and metabolic waste products. In erythrocytes, the function of intramembrane 
cation pumps, maintaining membrane fluidity, and intracellular signalling all 
depend on adenosine triphosphate (ATP). Erythrocyte ATP is generated primarily 
through glycolysis, also known as the Embden-Meyerhof pathway and is rather 
abundant intracellularly, with reported concentrations as high as 2 mM (2). ATP is 
composed of adenine covalently bound to a ribose monomer which is in turn bound 
to three organic phosphate groups (Figure 1.1).  
 
 
Figure 1.1 Structure of ATP (generated using ChemSketch) 
 
In addition to being the source of energy driving many intracellular processes, ATP 
is also released into the circulation where it acts as an extracellular signalling 
molecule. It has been documented that isolated erythrocytes from humans (3) (4) (5) 
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and rats (5) (6) release ATP in response to low O2 tension. In the vascular system, 
the application of low micromolar concentrations of ATP had been found to relax 
arterial tissues (7).  
 
1.2. NO production via ATP 
 
The control of blood flow in the peripheral circulation through the relaxation and 
constriction of blood vessels is regulated so as to ensure that the supply of oxygen 
adequately matches local demand. In working tissues where the demand for oxygen 
is considerably higher than when at rest, there is a concomitant an increase in blood 
flow (8). The increased flux of oxygen loaded erythrocytes from the arteries is local 
(as opposed to throughout the entire body) and occurs as a result of vasodilation  (9). 
The vascular system’s capacity to adjust the volume of blood vessels represents a 
key component of its ability to respond to the metabolic needs of organs and tissues. 
Vascular tissues (arteries and veins) are composed of several layers of different cell 
types working in concert to change the diameter of the vessel lumen. The 
endothelial cell layer (endothelium) lines the inside of blood vessels and as such is 
exposed to small molecules, such as ATP, that are in transit through the circulatory 
system. Receptors at the endothelium propagate the signal from circulating 
molecules to the smooth muscle cell layer, which in turn determines vascular tone. 
ATP binding to purinergic receptors at the endothelium activates endothelial Nitric 
Oxide Synthase (eNOS). When active, eNOS produces nitric oxide (NO) by 
catalyzing the two step oxidation of L-arginine to L-citrulline with oxygen and 
3 
 
NADPH serving as cofactors (Figure 1.2) (10). NO, formerly known as the 
endothelial derived relaxation factor, is a highly reactive free radical (10) which can 
readily diffuse to smooth muscle cells. NO initiates a signal cascade by activating 
guanylyl cyclase which leads to a decreased intracellular calcium concentration and 
results in smooth muscle relaxation (11). 
 
Figure 1.2 Schematization of the activity of endothelial nitric oxide synthase (eNOS) . 
(generated using ChemSketch) 
 
1.3. Nitrite and NO bioactivity 
 
As a freely diffusing small molecule, NO is also able to diffuse out of the 





 levels reflect eNOS activity and are considered to be an indicator of 
vascular health (12). In mammals, the concentrations of plasma and erythrocyte 
NO2
-




 (12). In 
fact, the erythrocyte has been described as a major storage site for NO2
-
 in human 
blood (13). Recently NO2
-
, which was long considered to be an inert oxidation 
       L-arginine                            N
ω
-hydroxy-L-arginine                L-citrulline 
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product of NO has been found to be vasoactive and has been shown to be reduced 
back to NO by deoxyhemoglobin (deoxyHb) in erythrocytes (14). However, because 
of the elevated concentration of hemoglobin (Hb) in erythrocytes, NO produced 
within the erythrocyte could not be exported, but rather would be scavenged (2). 
Recently, the English lab group has reported the production of a vasoactive 
compound following the exposure of erythrocytes to physiologically relevant 
concentrations of NO2
-
 (4). The export of ATP from erythrocytes in response to 
treatment with NO2
-
 represents a potential conservation for NO vasoactivity which 
is not strictly NO derived. 
 
1.4. Stimulated ATP release from erythrocytes  
1.4.1. Deaeration and hypercapnia 
 
The release of ATP from erythrocytes can be triggered by a number of physiological 
stimuli. The best documented stimulus of ATP release from erythrocyte is decreased 
oxygen saturation (3) (15) (16) (2). It is fairly common knowledge that Hb changes 
conformation upon binding and release ligands and in particular O2 and 
interestingly, the release of ATP from deaerated erythrocytes has been found to be 
more closely correlated with the conformation of Hb than with the actual saturation 
(17). However, recent research has that deoxyHb has a well-defined binding site for 
the erythrocyte membrane as well as a greater affinity for the erythrocyte membrane 
than oxyHb (18). DeoxyHb readily competes with glycolytic enzymes which can 
also bind the membrane (19). This competition gives rise to a regulated 
compartmentalization of ATP production near the membrane. The export of ATP 
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from a membrane localized pool, rather than from bulk, cytosolic ATP, has been 
suggested recently (20). Hypercapnia, elevated CO2 levels, as a stimulus of ATP 
release has been best documented when used in conjunction with hypoxia for 
erythrocytes (3), however, the release of ATP has been reported for other cells types 
following CO2 exposure and vasodilation has ensued (21). In addition, CO2 favors 
the release of O2 by Hb through the Bohr effect, promoting the formation of 
deoxyHb (22). Given these findings, the potential that hypercapnia alone might 
stimulate ATP release from erythrocytes is high. 
 
1.4.2. Mechanical deformation  
 
Mechanical deformation, a process that erythrocytes undergo when passing through 
the narrow blood vessels of the microcirculation, has been reproduced 
experimentally using porous membranes (23) and microbore tubing (16). In 
addition, hypo-osmotic stress, which induces swelling in erythrocytes, induces ATP 
release from human (24) and mudpuppy erythrocytes (25). Interestingly, the binding 
of Hb to the erythrocyte membrane has been characterised as a form of mechanical 
deformation of the membrane (26).  
 
1.5. Measuring ATP release 
The primary method used to assay ATP is using chemiluminescence. Throughout 
the course of this work, we will use the firefly luciferin-luciferase assay system to 
quantify ATP. Firefly luciferase catalyzes a reaction between ATP, luciferin, and O2 
to form AMP, inorganic pyrophosphate, oxyluciferin, CO2, and light (Figure 1.3). 
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Quantitative studies have determined that the quantum yield of the reaction is close 
to one photon per molecule of ATP which reacts with a molecule of luciferin (27).  
 
Figure 1.3  Chemiluminescence reaction catalyzed by the enzyme luciferase 
D-Luciferin reacts with ATP and molecular oxygen in the presence of Mg
2+
 to produce an 
excited state oxyluciferin and release AMP, pyrophosphate and CO2. The relaxation of excited 
state luciferin produces light in proportion to ATP concentration.  (generated using 
ChemSketch) 
 
This system is robust and very useful as there is a proportional relationship 
between the amount of ATP and the emitted light (λmax=560 nm). Of twelve 
naturally occurring nucleoside triphosphates, it has been determined that only 
ATP is effective and highly specific as a substrate for the light producing 
reaction of firefly luciferase. The next most effective nucleoside yielded a signal 
that was less than 2% as that of ATP (28). While other nucleoside triphosphates 
do not interfere with the assay, Hb and whole blood have been reported to 
interfere with the assay as Hb absorbs strongly in the visible region in which 







Figure 1.4 Overlap of emission spectrum of luciferin and the absorption 
spectrum of Hb. Visible spectrum of Hb overlayed with the range of luciferin emission. 
Adapted from Colin et al 2000 (29). 
 
The assay is sensitive to the ionic strength of the assay media (30).  Most work 
which involves assaying ATP in erythrocytes uses a form of physiological saline 
solution (PSS) (15) (4), a viscous plasma mimic which is isotonic to erythrocytes 
due to a high salt content. The concentrations of cations and anions used to 
evaluate the quenching of the chemiluminescence did not exceed low millimolar, 
whereas the composition of PSS includes sodium and chloride in excess of 100 
mM. 
 
1.6. Relevance of measuring ATP 
Impaired ability of erythrocytes to release ATP has been associated to the 







deformable and have been found to release less ATP when exposed to hypoxia as 
well as pharmacological stimulants (31). Similarly, erythrocytes exhibit reduced 
capacity to release ATP when made hypoxic following treatment with insulin, an 
experimental condition which mimicks hyperinsulinemia encountered in pre-
diabetes (2). Impaired ATP release from erythrocytes is also a characteristic of 
the pathology of primary pulmonary hypertension (32). Erythrocyte ATP release 
has the potential to be a metric of oxidative stress in the future, given the 
modulation of ATP release by reactive oxygen species (33). 
 
1.7. Scope and outline of thesis 
 
This manuscript based thesis details the work done measuring ATP in 
suspensions of intact erythrocytes by means of the luciferin-luciferase 
chemiluminescence assay. Chapter 2 reviews some of the initial challenges 
encountered in determining ATP concentrations in the suspensions of intact 
erythrocytes. The previous work undertaken by the English lab group with 
regards to NO2
-
-stimulated ATP release from human erythrocyte suspensions 
was revisited and in addition, the effect on ATP release of metHb stabilizing 
anions was evaluated.  Some preliminary work with rat erythrocyte suspensions 
were initiated in this chapter and brought to light certain considerations that are 
further explored in Chapter 3. In Chapter 3, we attempt to address some of the 
questions that arose from our preliminary work. This chapter is presented in the 
form of methodology-based publication which reviews the parameters necessary 
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to obtain consistent, accurate measurements of ATP from suspensions of intact 
erythrocytes. This chapter contains several complementary experiments which 
evaluate the interference that Hb, the primary erythrocyte protein, represents in 
the chemiluminescence assay for ATP and how this might be addressed. In 
Chapter 4, we present the experimental work that resulted from the methodology 
work covered in Chapter 3. In light of the interference that erythrocytes 
represent, we sought to compare the ATP concentrations in erythrocyte 
suspensions to that of their supernatants. In addition, we evaluate the 
accessibility of the ATP found in suspensions and the effect of different 
modulators of ATP release on the concentration determined in the suspensions 
and the supernatants. The totality of Chapter 4 is, likewise, presented in manuscript 





2. Chapter 2 Preliminary work in modulation of ATP release from intact 
erythrocytes in suspension 
 
2.1. Introduction 
In low O2 environments, erythrocytes release ATP into the circulation which stimulates 
vasodilation and improves O2 delivery. As described in the introduction, ATP-
stimulated vasodilation is mediated by nitric oxide (NO). In the circulation, NO 
bioactivity (as a vasodilator) is thought to be stored in the form of NO2
-
 which is present 
in both erythrocytes and plasma (~300 nM and ~120 nM NO2
-
 respectively)  (13).  
There are a number of proposed pathways by which NO2
-
 might act as a vasodilator 
including the production of NO2
-
-modified intermediates (34) or the production of 
diffusible NO donors such as N2O3 (35).  However, in most cases, NO2
-
-derived 
vasodilation is assumed to involve the production of NO within the erythrocyte, and 
cannot account for the aggressive scavenging of NO by intracellular Hb (2). Recently, 
the English lab group proposed a mechanism for NO2
-
 induced vasodilation that is not 
dependant on the production of NO within the erythrocyte. They reported that exposure 
to physiologically relevant concentrations of exogenous NO2
-
 induced ATP release from 
erythrocytes in vitro (4), a phenomenon which has also been observed in vivo (15). 
Furthermore, they reported that the vasoactive compound nitroglycerin (GTN) also 
stimulates ATP release from erythrocytes (4). GTN is a common vasodilator in the 
clinical setting and is thought to be metabolized to NO2
-
 (36) (37). In addition to 
stimulating ATP release from erythrocytes, both of these compounds have been shown 
to generate metHb (38) (39) (40). In fact, oral NO2
-
 treatment in rats (41) (42), and NO2
-
 
infusion in rats (41) and humans (43) (40) elicited a concomitant increase in metHb. 
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Furthermore, an important side effect to GTN therapy is a clinically important increase 
in metHb concentrations, which leads to a condition known as methemoglobinemia. The 
release of ATP from erythrocytes following NO2
-
 exposure could be related to the 
reactions of Hb with NO2
-
. It has been demonstrated that Hb binds to the erythrocyte 
membrane (18) and that a change in conformation of Hb was required for the release of 
ATP in low O2 conditions (17). NO2
-
-modified Hb has been found to have a higher 
affinity for the erythrocyte membrane than either deoxyHb or oxyHb (15). These 
findings compel us to consider whether metHb, which has high membrane affinity and 
is produced by the reaction of oxyHb with NO2
-
, might also play a role in vasodilation. 
There is a number of vasoactive, albeit potentially toxic, compounds which stabilize 
metHb. MetHb does not bind oxygen but can form bonds with a number of anionic 




) and cyanide (CN
-
) (44). In isolated 
arterial tissues, fluoride (45) and azide (46) have a dilatory effect and systemic 
vasodilation has been documented following exposure to hydrogen cyanide (47) in the 
clinical setting. In order to determine whether the formation of metHb could stimulate 
the release of ATP, the effects of preincubation with the salts of stabilizers of metHb; 
KCN, NaF and NaN3, were examined. Based on the dissociation constants for the 
ligands bound to (Table 1.1) and the fact that 100 nM NO2
-
 elicited increased ATP 
release from erythrocytes (4), 100 nM of NaNO2, KCN and NaN3 and 1 mM NaF were 




Table 2.1 Dissociation constant of metHb binding anions  
 






















 is that recently reported in a metHb study (49) 
2.2. Materials and methods 
Adenine 5-triphosphate disodium salt, bovine serum albumin, EGTA, NaNO2, NaN3, 
KCN, NaF, MgCl2, and firefly lantern extract were purchased from Sigma–Aldrich 
(St. Louis, MO). The suppliers of the other chemicals were as follows: KCl from 
Fisher Scientific, Pittsburgh, PA; CaCl2, MgSO4 from ACP Chemicals, (Montreal, 
QC); NaCl; tris (hydroxymethyl) aminomethane from Bio Basic Inc, (Markham, ON), 
dextrose and Hepes from Bioshop (Burlington, ON); Distilled water was purified 
using a Milli-Q Simplicity 185 System (Millipore, Billerica, MA). White, non-sterile, 
polystyrene flat bottomed 96 well assay plates were purchased from Corning 
(Corning, NY). Physiological salt solution (PSS) was prepared fresh for each 
experiment with a final concentration (mM) of 4.7 KCl, 2.0 CaCl2, 1.2 MgSO4, 140.5 
NaCl, 21 tris(hydroxymethyl)aminomethane, 5.5 D-glucose and 0.5% w/v bovine 
serum albumin. Sucrose buffer was made from 321.5 mM sucrose, 32.1 mM HEPES, 
6.42 mM MgCl2, 2.63 mM EGTA.  The pH of PSS of both of the solutions was 
adjusted to 7.4. For human erythrocyte preparations, NaNO2, NaN3, KCN and NaF 
stock solutions were prepared as 50 fold stock solutions in 5% w/v D-glucose. For rat 
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erythrocyte preparations, a stock solution of 20 mM NaNO2 in PSS was serially 
diluted to 200 nM.  
 
The luciferase enzyme assay solution was prepared by dissolving 1.3 mg/mL firefly 
lantern extract in water and contained 2.6 mM MgSO4 and 7.8 mM potassium 
phosphate (50). The assay solution was protected from light for the duration of the 
experiment and used within 4h of being prepared. A 2.5 mM ATP stock solution was 
prepared by dissolving 6.9 mg ATP in 5 mL PSS. ATP standard solutions (5 nM-20 
μM) were prepared by diluting aliquots of the stock ATP solution in PSS.  All 
solutions were prepared using reverse-osmosis water purified using a Milli-Q 
Simplicity 185 system. 
 
2.2.1. Measurement of ATP by chemiluminescence  
The assay was initiated by mixing 100 L of the assay solution with 100 L of ATP 
standard in a white 96-well plate in triplicate and then the chemiluminescence signal of 
the standards was recorded. Likewise, 100 μL aliquots of erythrocyte suspension were 
assayed by the addition of 100 μL of assay solution. The chemiluminescence intensity in 
the wells was measured immediately following 2 s of gentle mixing.  The background 
chemiluminescence was determined by diluting a 100 μL aliquot of assay solution with 
100 μL of PSS and this signal was subtracted from those of the standards and the 




2.2.2. Sample preparation 
Whole blood was collected into 4 mL lithium heparin coated Vacutainer™ brand tubes 
obtained by venipuncture from healthy human female volunteers. The volunteers, aged 
25-35 year old, of varying ethnicities and fitness levels had been duly consented in 
accordance with the University Human Research Ethics Committee (UHREC) of 
Concordia University.  Female Wistar rats 375–450 g were housed and anesthetised in 
adherence with the research and teaching guidelines of the Canadian Council on Animal 
Care (CCAC) as per the University Animal Research Ethics Committee (UAREC) of 
Concordia University.  The rats were anesthetised by 1-2 min of CO2 inhalation and 
blood was obtained by cardiac puncture. Using a heparinised needle, a technician 
collected up to 3 mL of whole blood from each animal.  The blood was then transferred 
to 4 mL lithium heparin coated Vacutainer™ brand tubes and kept on ice until 
centrifugation.  
 
Within 2-4 h of collection, aliquots of blood were centrifuged at 1700 g at room 
temperature for 10 minutes.  The plasma, platelets and white blood cells were removed 
by aspiration and the packed eyrthrocytes were then resuspended and washed three times 
in an equal volume of PSS. Packed human erythrocytes were suspended at 2% hematocrit 
(Ht) at 37°C in 10 mL of sucrose buffer with 6 mM glucose and either no ligand as a 
control, 100 nM (for samples treated with NaNO2, NaN3 and KCN) or 1 mM (NaF) of 
ligand final concentration. Following pre-incubation with a ligand, 1 mL aliquots of 
erythrocyte suspension were removed and centrifuged at 1700g for 45 seconds.  The 
supernatant was removed by aspiration, the human erythrocytes resuspended at 1% Ht  in 
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1980 μL of fresh PSS and then assayed as described above.  Rat erythrocytes were 
suspended at 2% Ht and preincubated at 37˚C in either 100 nM NaNO2 in PSS or 
untreated PSS as a control. Following pre-incubation, the erythrocytes were then spun 
down, the supernatant removed, the cells resuspended at 1% Ht and assayed as described 
above.  
2.2.3. Data processing and statistical analysis 
Data was processed using Microsoft Office Excel and plotted using Origin Pro 8.1 
(OriginLab, Northampton, MA). Origin Pro 8.1 was also used for the ANOVA statistical 
analysis. The Spectra Max L luminometer used Molecular Devices’ SoftMax Pro5. 
2.3. Results 
2.3.1. ATP assay results  
Table 2.2. Blank-corrected chemiluminescence signal intensity of preincubated 
erythrocytes following resuspension at 1% Ht in PSS (RLU x10
5
) 
 <30 s 2 min 5 min N 
ControlNaNO2 7.05 ± 0.63 6.05 ± 0.80 5.29 ± 0.52 6 
100 nM NaNO2 7.38 ± 0.75 5.97 ± 1.31 4.91 ± 0.15 6 
Control 6.90 ± 0.81 5.76 ± 0.67 4.95 ± 0.37 3 
100 nM NaN3 6.89 ± 0.19 5.85 ± 0.60 4.69 ± 0.70 3 
100 nM KCN 6.25 ± 0.75 5.51 ± 0.67 4.92 ± 0.63 3 
1 mM NaF 6.73 ± 0.39 5.46 ± 0.17 4.24 ± 0.10 3 
 
Erythrocyte suspensions at 1% Ht were preincubated for <30 s-5 min in metHb stabilizing ligands NaNO2, 
NaN3, KCN or NaF in PSS. The suspensions were centrifuged and resuspended in fresh PSS, aliquoted into 
a 96 well plate and assayed as described in section 2.2. 
Whether human erythrocytes were preincubated for up to 30 s, 2 min or 5 min with an 
anion, there was not a statistically significant change in the signal recorded as compared 
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to their time-matched controls (Table 2.2). The notable exception to this is the 5 min 
preincubation with NaF, wherein there was a significant decrease compared to the time 
matched control (p < 0.05).  For all samples, whether treated or not, the signal intensity 
decreased as a function of preincubation time. These values were transformed to ATP 
concentrations (Table 2.3) using the calibration curves which were generated using ATP 
standards prepared as described in the methods. The concentrations determined for the 
erythrocyte samples ranged from 0.7 to 1.2 µM ATP. The decrease in signal intensity 
with time is equivalent to approximately 50 nM ATP /min.  Throughout the course of this 
thesis, ATP values will often be presented as normalized extracellular ATP in order to 
best demonstrate the effect of a preincubation on the determined ATP concentration for 
erythrocytes. The ATP concentrations determined for each of the incubations is then 
divided by their respective controls to obtain a unit-less ratio of ATP concentrations. This 
final data transformation was performed on the determined ATP from Table 2.3 and is 
presented in Table 2.4. 
Table 2.3 ATP concentration of preincubated erythrocytes following resuspension at 
1% Ht in PSS calculated by linear regression (μM) 
 <30 s 2 min 5 min N 
ControlNaNO2 1.13 ± 0.10 0.97 ± 0.13 0.85 ± 0.08 6 
100 nM NaNO2 1.18 ± 0.12 0.95 ± 0.21 0.78 ± 0.23 6 
Control 1.10 ± 0.13 0.92 ± 0.11 0.79 ± 0.06 3 
100 nM NaN3 1.10 ± 0.03 0.94 ± 0.10 0.75 ± 0.11 3 
100 nM KCN 1.00 ± 0.12 0.88 ± 0.11 0.79 ± 0.10 3 
1 mM NaF 1.08 ± 0.06 0.87 ± 0.03 0.68 ± 0.02 3 
 
The data from Table 2.1 was transformed using blank corrected calibration curves in order to determine the 





Table 2.4 Normalized extracellular ATP of preincubated erythrocytes following 
resuspension at 1% Ht in PSS 
 <30 sec 2 min 5 min N 
100 nM NaNO2 1.05 ± 0.04 0.98 ± 0.19 0.92 ± 0.24 6 
100 nM NaN3 1.01 ± 0.10 1.02 ± 0.04 0.94 ± 0.07 3 
100 nM KCN 0.91 ± 0.11 0.96 ± 0.12 0.99 ± 0.08 3 
1 mM NaF 0.98 ± 0.07 0.96 ± 0.12 0.86 ± 0.04 3 
 
The data which was used to create data 2.2 was used to determine the fold change in ATP concentration of 
the 1% Ht erythrocyte suspensions in PSS following preincubation with metHb stabilizing ligands 
 
The initial work performed by the English research group on NO2
-
-stimulated ATP 
release from human erythrocytes pre-incubated at 2% Ht and assayed at 1% Ht, had 
recorded ATP concentrations in the low nanomolar range (4). Similarly, when using 
identical Ht and methodology we obtained ATP concentrations that were up to an order 
of magnitude higher.  Given erythrocytes’ millimolar intracellular ATP concentration, it 
was deemed possible that rupture of the erythrocytes, known as hemolysis, could have 
been a factor in producing these elevated ATP concentrations. Without centrifuging the 
erythrocytes and measuring the Hb content of their supernatants, it is not possible to 
obtain an accurate measure of sample hemolysis. As this had not been done, a theoretical 
index of hemolysis was determined for the samples.  
 
2.3.2. Approximation of sample hemolysis 
Bergfeld and Forrester (3) determined the extent of hemolysis by calculating the 
maximum number of molecules of ATP released per cell following 100% hemolysis.  




Approximation of the number of cells:  
 
1% Ht = 50 000 cells*μl-1 
For 100 μL of erythrocytes at 1% Ht 
  cells=50000 cell μL 1 100 μL=5 10  cells 
   molecules ATP=   ATP M  .022 1023molecules Moles   2 10
-4L  
  molecules ATP cell
 1
=( ATP M  .022 1023 molecules Moles  2 10
 4L)
5 10 cells 
  






% hemolysis =   molecules ATP cells
 1
  .3 107molecules ATP cells 1
  
Table 2.5 Approximation of the maximum possible % hemolysis of preincubation 
erythrocytes in presence and absence of 100 nM NaNO2 
 
The approximation of the maximum possible hemolysis following <30 s- 5 min preincubation of 
erythrocytes with 100 nM NaNO2. Based on the ATP concentrations determined in Table 2.2 and 
the calculations used in previous work related to assay ATP from lysed erythrocytes. 













 Mean SD Mean SD Mean SD Mean SD 
ctrl <0.5 min 1.13 0.10 1.36 0.12 2.72 0.24 43.16 3.84 
ctrl 2 min 0.97 0.13 1.17 0.16 2.33 0.31 37.03 4.94 
ctrl 5 min 0.85 0.08 1.02 0.10 2.04 0.20 32.34 3.20 
NaNO2<0.5min 1.18 0.12 1.42 0.15 2.85 0.29 45.20 4.63 
NaNO2 2 min 0.95 0.21 1.15 0.25 2.30 0.51 36.52 8.06 
NaNO2 5 min 0.78 0.23 0.946 0.28 1.89 0.56 30.03 8.88 
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Table 2.6 Approximation of the maximum possible % hemolysis of preincubation 
erythrocytes in presence and absence of 100 nM NaN3, 100 nM KCN or 1 mM NaF. 
 










 % hemolysis 
 Mean SD Mean SD Mean SD Mean SD 
ctrl <0.5 min 1.10 0.13 1.33 0.16 2.66 0.16 44.32 2.48 
ctrl 2 min 0.92 0.11 1.11 0.13 4.32 0.13 35.27 2.05 
ctrl 5 min 0.79 0.06 0.95 0.07 1.91 0.07 30.28 1.14 
NaF <0.5 min 1.08 0.06 1.30 0.08 2.60 0.08 41.22 1.19 
NaF 2 min 0.87 0.03 1.05 0.03 2.10 0.03 33.39 0.52 
NaF 5 min 0.68 0.02 0.82 0.02 1.63 0.02 25.91 0.31 
NaN3 <0.5min 1.10 0.03 1.33 0.04 2.66 0.04 42.15 0.59 
NaN3 2 min 0.94 0.10 1.13 0.12 4.35 0.12 35.78 1.85 
NaN3 5 min 0.75 0.11 0.90 0.14 1.81 0.14 28.66 2.14 
KCN<0.5 min 1.00 0.12 1.20 0.15 2.41 0.15 38.23 2.3 
KCN 2 min 0.88 0.11 1.06 0.13 2.13 0.13 33.74 2.05 
KCN 5 min 0.79 0.10 0.95 0.12 1.90 0.12 30.11 1.93 
 
The approximation of the maximum possible hemolysis following <30 s- 5 min preincubation of 
erythrocytes with 1 mM NaF or 100 nM KCN or NaN3. Based on the ATP concentrations determined in 
Table 2.2 and the calculations used in previous work related to assay ATP from lysed erythrocytes. 
 
Using an approximation based on the methods of Bergfeld and Forrester (3), the human 
erythrocyte suspensions underwent a maximum of anywhere from 25-45% hemolysis 
(Table 2.5 and 2.6). However, we must yet explain how it would be possible for there to 
be a decrease in ATP with time if the erythrocytes were indeed undergoing lysis. It would 
stand to reason that we would observe an increase in ATP concentrations with time, as 
more and more cells would be lysed under the experimental conditions that were able to 
induce over a quarter of the cells to lyse. Erythrocytes have a number of enzymes which 
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consume ATP for various cell maintenance functions, such as pumping cations across the 
erythrocyte membrane. The activity of these ATPases could account for the decrease in 
ATP observed over time in the sample suspensions.  
 
2.3.3. Rat erythrocytes 
 
The opportunity to work with erythrocytes collected from Wistar rats presented itself. 
Given the importance of rodents as pharmacological models, we opted to take advantage 
of the availability of samples.  Rat erythrocytes were preincubated and assayed without 
the use of a sucrose buffer, which originally served as an osmoprotectant for prolonged 
incubations (4). The signal intensities for the rat erythrocytes chemiluminescence (Table 
2.7) and the corresponding ATP concentrations (Table 2.8) were an order of magnitude 
lower than those recorded for human erythrocytes. Furthermore, the NaNO2-treated 
samples were consistently lower than the control samples, which would indicate that 
NaNO2 was actually attenuating the release of ATP from rat erythrocyte suspensions by 
20% to 40%, which was in direct contradiction of the increase in erythrocyte ATP release 
documented in recent literature  ((4), (15)). However, there was a marked decrease in the 
triplicate values recorded for most of the rat erythrocytes suspensions which gave rise to 
standard errors of 19% to 42% of the average (CV values in Table 2.7). On average, the 





Table 2.7. Effect of 30 s preincubation of erythrocyte suspensions to 100 nM NaNO2 








- 4.57 4.25 2.36 3.73 
+ 3.50 2.51 2.56 2.86 
- 4.14 3.26 2.60 3.33 
+ 3.74 2.32 1.59 2.55 
- 4.95 3.03 3.11 3.70 
+ 3.93 2.57 2.78 3.09 
- 3.45 4.38 2.36 2.70 
+ 2.02 1.52 1.27 1.61 
 
Rat erythrocytes obtained by cardiac puncture and prepared as described in section 2.2. Blank corrected 
chemiluminescence signal intensity of erythrocytes following 30 s exposure to PSS (-) or to 100 nM 
NaNO2 (+) and resuspension at 1% Ht in PSS (RLU x10
4
) Italicized samples assayed by D.Di Marco 
 
Table 2.8. Effect of 30 s preincubation of erythrocyte suspensions to 100 nM NaNO2 







 Average CV% 
- 487 454 255 399 31% 
+ 375 271 277 307 19% 
- 443 350 281 358 23% 
+ 400 251 174 275 42% 
- 528 326 334 396 29% 
+ 420 277 299 332 23% 
- 370 246 255 290 24% 
+ 219 167 141 176 23% 
 
Rat erythrocytes obtained by cardiac puncture and prepared as described in section 2.2. ATP concentrations 
(nM) determined based on data from Table 2.6. for erythrocytes following 30 s exposure to PSS (-) or to 








The primary difference between the present material and methods and those published by 
this lab group in the past is the use of 0.1% dextrose in the PSS instead of 0.2%.  The 
PSS was made in this manner following the recipes provided by the authors, which 
differed from the published concentrations.  PSS, dextrose not withstanding has an 
osmolarity of 296.8 mOsm/L; 0.2% w/v dextrose brings the osmolarity to 307.8 mOsm/L.  
The use of 0.1% w/v dextrose would give the PSS an osmolarity of 302.3 mOsm/L, 
which is similar to the normal osmolality of erythrocytes - 300 mOsm/kg (51).  If the 
elevated levels of ATP measured for the human blood samples were due to hemolysis, 
the source of said hemolysis remains undetermined. Originally, we posited that a reduced 
final glucose concentration might have contributed to sample hemolysis, but it could also 
be due to a number of factors including an error in the concentration of osmolytes in the 
physiological saline solution used to prepare the samples. It is important to note that the 
degree of hemolysis determined was in no way reflected in the visual aspect of the 
samples. In fact, in absence of visible spectroscopy of sample supernatants, all statements 
with regards to hemolysis remain highly speculative. 
The amount of ATP released from human erythrocytes decreased over time for both the 
controls and the treated cells.  The time dependant decrease in the amount of ATP 
measured is most likely the result of the activity of nucleases.  In addition, the 
accumulation of ADP, an ATP degradation product, would occur over time, and ADP 
binding to the P2Y receptors on the erythrocyte could readily inhibit ATP release (52). 
When repeating these manipulations, it will be essential to centrifugate the erythrocytes 
and measure the Hb content of the supernatants in order to more accurately evaluate the 
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degree of hemolysis of the samples.  Using Bergfeld and Forrester’s correlation between 
% hemolysis and OD560, we would expect an absorbance of ~0.09 at 560 nm for 40% 
hemolysis, and so roughly 0.9 in the soret region (3). Erythrocyte hemolysis is generally 
evident in the physical aspect of the erythrocyte suspensions. There is a marked transition 
from opacity to translucence with increased hemolysis, which was not observed. While 
the % hemolysis determined above is an approximation, the erythrocyte suspension and 
supernatant did not present any evident signs of over one third of the cells having been 
hemolyzed.  In light of the extent of hemolysis, the decrease in ATP levels over time is 
more likely due to degradation of ATP than the inhibition of ATP release from the cells 
due to the products of said degradation.  
The rat erythrocyte samples were prepared using a fresh stock of Ringer’s and Tris base 
solutions and the ATP concentrations determined were in line with those documented. 
The downward trend in the ATP concentration with time is evocative of ATP 
degradation. That this also occurred with the rat erythrocyte samples brought this matter 
to the forefront of our experimental considerations. ATP degradation has been posited by 
several lab groups (53) (4) in light of the documented presence of vascular ATPases. 
However, the loss of signal could also be due to the transience of the light emitted during 
the reaction of oxyluciferin with ATP, whose decay can vary from very fast (<1 sec), to 
rather slow (> 5 min) (54).   The decrease in signal within triplicate readings was 
indicative of the signal being recorded too long after the initiation of the assay. From this 
observation, the decay of the oxyluciferin signal became the first of a number of factors 
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As erythrocyte-derived extracellular ATP gains recognition as an essential, local 
vasodilator in blood, improving the accuracy and simplicity of its determination in 
erythrocyte suspensions is increasingly necessary. However, the luciferin-luciferase 
chemiluminescence assay for ATP has not been systematically evaluated for intact 
erythrocyte suspensions. Whole blood and Hb contribute to matrix effects on the 
luciferin signal and we hypothesize that Ht constitutes the main matrix effect in the 
chemiluminescence quantitation of ATP in erythrocyte suspensions. ATP standard 
curves in presence of Hb, standard addition, and dilutions of erythrocyte suspensions 
were employed to evaluate matrix effects. We found that Hb attenuated the 
chemiluminescence signal of ATP standards in a dose-dependent manner. Moreover, 
using standard addition, we established the maximum Ht at which the 
chemiluminescence signal for added ATP was not affected by the presence of 
erythrocytes in the assay matrix. Finally, we report that the extracellular ATP-derived 
chemiluminescence signal from erythrocyte suspensions is bimodal as a function of 
Ht. Ultimately, erythrocytes’ interference in the measurement of their extracellular 
ATP by chemiluminescence can be limited by working at very low Ht. This finding 
coupled with optimized assay parameters for a 96-well plate, increases the throughput 
of the assay while requiring mere micro-litres of blood. 
3.2. Introduction 
 
Erythrocytes act as effectors in the circulatory system through their release of ATP. In 
the lumen of blood vessels, ATP is an extracellular signalling molecule, which 
increases blood vessel diameter by stimulating endothelium-dependent vasodilation 
26 
 
(53). In vitro, erythrocyte-derived ATP has been measured in lysates (55) (56), 
supernatants (24), and suspensions (56) (16) (3), using the luciferin-luciferase 
chemiluminescence assay. The strength of this assay lies in the fact that the light 
producing reaction of ATP with oxyluciferin is catalyzed by luciferase and has a 
quantum yield of very close to 1 (54) (Figure 3.1). 
 
Figure 3.1. Chemiluminescence reaction catalyzed by the enzyme luciferase 
D-Luciferin reacts with ATP and molecular oxygen in the presence of Mg
2+
 to produce an excited state 
oxyluciferin and release AMP, pyrophosphate and CO2. The relaxation of excited state luciferin produces 
light in proportion to ATP concentration (generated using ChemSketch). 
 
We sought to establish the limitations of this assay when using a standard 
chemiluminescence plate reader to measure erythrocyte-derived ATP. Therefore, we 
evaluated the thermal stability of luciferase, the decay of the signal emitted under typical 
assay conditions as well as the effect of various interfering molecules on the recorded 











, quench the signal emitted by oxyluciferin (57) (30) when 
present in the millimolar range (1-100 mM). The physiological saline solution (PSS) used 
to prepare an erythrocyte suspension contains these and other ions in the range of 1-140 
mM. PSS is a necessity when working with intact erythrocytes because it has an 
osmolality comparable to that of the plasma, serum and whole blood of a large number of 
mammals, including rats and humans (~300 mOsm/kg) (51), hence keeping erythrocytes 
intact. As our work involves investigations of osmotic pressure-induced ATP release, we 
examined the effect of the percent (by volume) of PSS on the signal strength recorded for 
the chemiluminescence assay.  
 
Both whole blood and Hb interfere with the assay due to Hb’s strong absorption in the 
region of oxyluciferin emission (500-650 nm) (29). The percent volume of erythrocytes, 
or Ht, dictates its Hb concentration and is a key parameter when assaying erythrocyte 
ATP. The goal of this study was to determine extracellular ATP concentrations of intact 
erythrocytes in suspension quantified using the luciferin-luciferase chemiluminescence 
assay using a 96-well plate reader. We hypothesized that there would be significant, Ht-
dependent absorption of the chemiluminescence by the erythrocytes due to their high Hb 
content. This inner-filter effect was evaluated and we examined different strategies to 
correct for the presence of erythrocytes in the sample suspensions. The accurate 
determination in erythrocyte suspensions revealed a few caveats. Surprisingly, the 
workhorse for ATP assays, the luciferin-luciferase base chemiluminescence assay had not 







Adenine 5-triphosphate disodium salt, bovine serum albumin, bovine metHb, and firefly 
lantern extract were purchased from Sigma–Aldrich (St. Louis, MO). The suppliers of the 
other chemicals were as follows: KCl from Fisher Scientific, Pittsburgh, PA; CaCl2, 
MgSO4 from ACP Chemicals, (Montreal, QC); NaCl; tris (hydroxymethyl) 
aminomethane from Bio Basic Inc, (Markham, ON); Hepalean 1,000 U/mL heparin 
Organon Canada (Scarborough, ON); dextrose from Bioshop (Burlington, ON); Distilled 
water was purified using a Milli-Q Simplicity 185 System (Millipore, Billerica, MA). 
Physiological salt solution (PSS) was prepared fresh for each experiment with a final 
concentration (mM) of 4.7 KCl, 2.0 CaCl2, 1.2 MgSO4, 140.5 NaCl, 21 
tris(hydroxymethyl)aminomethane, 11 D-glucose and 0.5% w/v bovine serum albumin. 
The pH was adjusted to 7.4 with 10 N HCl. White, non-sterile, polystyrene flat bottomed 
96 well assay plates were purchased from Corning (Corning, NY). 
 
3.4. Methodology 
3.4.1. Measurement of ATP by chemiluminescence  
The luciferase assay solution used to quantify ATP was prepared just prior to use by 
dissolving 1.3 mg/mL firefly lantern extract, containing both luciferin and luciferase, in 
fresh Milli-Q water. In addition to luciferin and luciferase, the resulting assay solution 
also contained 7.8 mM potassium phosphate and 2.6 mM magnesium sulphate (58). The 
solution was mixed by gentle rocking and centrifuged at ambient temperature for 10 min 
at 3300 g using an IEC GP8R centrifuge. The supernatant was decanted into a foil 
wrapped Falcon tube and aliquots were poured into a foil covered reservoir for use with a 
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12-channel multichannel pipettor (Eppendorf). A 2.5 mM ATP stock solution was 
prepared by dissolving 6.9 mg of ATP (weighed on a Mettler Toledo MX5 microbalance) 
in 5 mL fresh PSS and stored at -20°C. Aliquots of the stock solution were thawed and 
diluted 1000-fold in PSS to give a 2.5 M solution, which was used to prepare standards 
ranging from 10 to 1500 nM ATP in PSS. The ATP standards were kept on ice and 
equilibrated to 23°C in the plate reader. The assay was initiated by mixing 100 L of the 
assay solution with 100 L of ATP standard in a white 96-well plate in quadruplicate. 
The plates were kept in the dark prior to the experiments to minimize plate 
phosphorescence from exposure to a combination of natural and fluorescent light. The 
chemiluminescence signal of the standards was recorded with a Spectra Max L plate 
reader at 23°C. A calibration curve in the nanomolar range was generated by plotting the 
signal intensities relative to a blank (in relative light units, RLU) of the standards vs. 
[ATP].  
 
In our studies of stimulated ATP release, the erythrocytes are maintained at 37°C; it 
would be desirable to assay ATP in suspensions at this temperature. The stability of 
luciferase assay solution at 37°C was examined. The assay solution was prepared as 
described above, placed in a 37°C water bath for 5 to 30 min and then used to assay ATP 
standards which were kept on ice. 
3.4.2. Decay of chemiluminescence vs. time 
The chemiluminescence signal was monitored to establish the time frame in which the 
signal decay could be determined. A 100 L aliquot of 400 nM ATP standard solution in 
PSS into a 96-well plate and the assay was initialized by the addition 100 L of assay 
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solution. A total of 200 readings were taken every 0.1 s over 20 s and a total of 60 
readings were taken every 5 s over 5 min. 
3.4.3. Inner filter effect of Hb on chemiluminescence 
Whole blood from female Wistar rats has a mean Ht of 50% and a mean Hb 
concentration of 2.63 mM (170 mg/mL) (12). A 1% Ht suspension is a 50-fold dilution of 
erythrocytes with a Hb concentration of ~53 M (3.4 mg/mL). ATP standards with final 
concentrations of 0, 50, 500 or 5000 nM prepared in PSS, were assayed with metHb 
solutions of 0.51-256 M (equivalent to approximately 0.01-5% Ht) in 96-well plates. 
 
3.4.4. Blood collection, preparation and assay of erythrocyte samples  
Female Wistar rats 375–450 g were housed and anesthetised in adherence with the 
research and teaching guidelines of the CCAC as per the UAREC of Concordia 
University.  Rats were restrained, and a small portion (<1 cm) of the animal’s tail was 
removed using a straight razor. Blood flow from the tail was ensured by gentle stroking 
the tail from the base to the tip. Up to 1 mL of whole blood was collected in lithium 
heparin coated BD microtubes by this method.  
 
Informed written consent was obtained from healthy adult human female volunteers, ages 
18-30 years of varying ethnicity and fitness levels. The collection and use of blood from 
human volunteers were in accordance with the UHREC of Concordia University. Blood 
was collected into 4 mL heparinised tubes by venipuncture from a tourniqueted 
antecubital vein and kept on ice until centrifugation.  
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Within 1 h of collection, an aliquot of whole rat or human blood was transferred into a 2-
mL Eppendorf tube and centrifuged in a Micromax RF Thermo IEC at 1700 g for 5 min 
at 4°C.  Following centrifugation, the plasma and the fraction containing white blood 
cells and platelets were removed by aspiration with a micropipettor.  An equal volume of 
PSS was added to the packed erythrocyte sample.  The cells were suspended by gently 
pipetting up and down and then centrifuged as above. The supernatant was replaced with 
fresh PSS kept at ambient temperature and the cells were washed in this manner two 
more times.  During the wash steps, a small volume of packed erythrocytes was removed 
to ensure that none of the plasma and other cell types remained.  
 
3.4.5. Standard Addition 
To examine the chemiluminescence signal intensity of erythrocyte suspensions as a 
function of % Ht, a 1% Ht suspension of rat erythrocytes was prepared in PSS. The 1% 
Ht suspension was diluted with PSS to give a range of erythrocyte suspensions with Ht 
varying from 0.01 to 0.6% which were assayed for ATP as described above. Alternatively 
the method of standard addition was used to determine the amount of ATP in the 
suspensions. Aliquots of the ATP stock solution in PSS were added to suspensions to 
give final ATP concentrations of 0-500 nM ATP in 1 mL suspensions of 0.25%-0.0039% 
Ht. The signal intensities were plotted versus [ATP] and the x-intercept of extrapolated 





3.5.1. Time course of chemiluminescence decay 
The chemiluminescence signal was measured within 10 s of adding 100 L of luciferase 
assay solution to 100 L of ATP standard in a 96-well plate. Figure 3.2 shows the time 
course of signal decay from a well containing 200 nM final concentration. Over the 
course of 5 min, we observed a 40% decrease in the signal but a strong 
chemiluminescence signal was present after 5 min. The decay of the emission from the 
relaxation of high energy oxyluciferin was fitted exponentially and the half-life of the 
signal was estimated to be 10.1 ± 0.9 min.  
 




























Time (min)  
Figure 3.2 . Decay over 5 min of the chemiluminescence emission from oxyluciferin. 
The ATP-driven luciferase-catalysed oxidation of luciferin was initiated in a 200 L solution containing 
200 nM ATP, pH 7.4 at 23°C. The signal intensity (relative light units, RLU) was integrated over 1 s and 


































Figure 3.3. Decay over 20s of the chemiluminescence emission from oxyluciferin. The 
ATP-driven luciferase-catalysed oxidation of luciferin was initiated in a 200 L solution containing 200 
nM ATP, pH 7.4 at 23°C. The signal intensity (relative light units, RLU) recorded every 0.1 s for a total of 
200 readings over 20 s. Inset data with y-axis expanded. 
The emission was also measured over 20 s (Figure 3.3) since the time required for the 
luminometer to measured quadruplicate wells is 10 s. The negative slope corresponds to a 
decay of 4% within 20 s of the assay being initiated. Expansion of the y-axis reveals the 
distribution of the data points (inset Figure 3.3). A linear fit of the data shows an equal 









































3.5.2. Effect of preincubation of assay solution at 37˚C 































[ATP] (nM)  
Figure 3.4. Preincubation of assay solution at 37°C decreases slope of the calibration 
curve. The luciferase assay solution was preincubated in a water bath at 37°C and 100 L aliquots were 
added to 100 L of ATP standards, pH 7.4 at 23°C following 0 (), 5 (), 10 (), 20 (), and 30 () 
min preincubation. The signal intensity was recorded immediately after the initiation of the assay by the 
addition of the luciferase assay solution. Note that the data points at 10, 20 and 30 min overlap. 
 









 values of data in Figure 3.4. The luciferase assay solution was preincubated in a water bath 
at 37°C and 100 L aliquots were added to 100 L of ATP standards, pH 7.4 at 23°C following 0, 5, 10, 20 
and 30 min preincubation. The signal intensity was recorded immediately after the initiation of the assay by 
the addition of the luciferase assay solution.  
Time (min) Slope (RLU/nM) R
2
 
0 350 0.997 
5 175 0.962 
10 8.8 0.998 
20 1.4 0.955 
30 1.7 0.889 
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Following a 5 min preincubation of the assay solution at 37°C, the signal recorded was 
50% lower than t=0 (Figure 3.4); this is in good agreement with previous work reporting 
a 50% decrease after 4 min at 37°C (59). Following 10 min preincubation at 37°C, the 
signal decreased by >95%, however the standard curves remained linear for up to 30 min 
(Table 3.1).  
 















Figure 3.5. Reducing the salt concentration increases the chemiluminescence signal. 
ATP standards were prepared in PSS (), 60% PSS (60:40 v/v PSS:Milli-Q water) () or in Milli-Q water 
(). In each case, 100 L of the luciferase assay solution were added to 100 L of ATP standards, pH 7.4 
at 23°C. The signal intensity was recorded immediately after the initiation of the assay by the addition of 
the luciferase assay solution.  
 
Compared to the 100% PSS control, diluting PSS to 60% increased the slope of the 
standard curve over 2 fold from 185 to 440 RLU per nM ATP (Figure 3.5). Preparation of 































the standards in Milli-Q water resulted in a slope of 1891 RLU per nM ATP; 10 times 
higher than the slope of calibration curve prepared with 100% PSS. As reported 
previously, the assay is highly sensitive to the total salt concentration of the medium (30) 
(57). We also examined the calibration curve in PSS with 80.7 mM NaCl, (the main 
osmolyte) but with the same concentration of other solutes to probe for specific ion 
effects. The slope increased 1.7-fold, from 194 to 329 RLU per nM ATP compared to 
that obtained using 100% PSS (data not shown).  
 
3.5.4. Inner-filter effect of Hb on the chemiluminescence signal 

































Figure 3.6 Inner-filter effect of metHb on the ATP calibration curve:  Control: 
standards prepared in PSS.  standards prepared in PSS containing 15.3 M metHb. metHb: standards 
prepared in PSS containing 51 M metHb.  metHb: standards prepared in PSS containing 153 M 
metHb. In each case, 100 L of the luciferase assay solution were added to 100 L of ATP standards, pH 
7.4 at 23°C. The signal intensity was recorded immediately after the initiation of the assay by the addition 




Table 3.2 Inner-filter effect of metHb on the calibration curve 
[Hb] (M) Slope (RLU/nM) R2 
0 7130 0.997 
15.3 4004 0.997 
51 2019 0.995 




 values of data in Figure 3.6. The assay was initiated by the addition of 100 L of luciferase 
assay solution to 100 L of ATP standards prepared in metHb treated PSS, pH 7.4 at 23°C. The signal 
intensity was recorded immediately after the initiation of the assay. The signal recorded in the presence of 
metHb is significantly lower than with PSS alone (Figure 3.6). 
 
The commercial metHb preparations decreased the slope of the calibration curve in a 
dose dependant manner (153 M: y=603x, 51 M: y=2162x, 15.3 M y=4004x 
compared to the control y=7130x) (Figure 3.6).  In Figure 3.7, varying metHb 
concentrations were assayed in the presence of a series of fixed concentrations of ATP. 
For any given concentration of ATP, there is a rapid, stoichiometric decrease in the 
chemiluminescence signal recorded up to 5.13 M metHb; above 5.13 M, the signal 
decrease slows considerably. It is important to note that 5.13 µM is equivalent to the Hb 
concentration of a 0.1% Ht erythrocyte suspension.  At all concentrations of ATP, the 
chemiluminescence signal recorded as a function of the concentration of metHb present 
in solution was related via double exponential trend. As in Figure 3.6, for any given 
concentration of metHb, a plot of the chemiluminescence signal recorded as a function of 





3.5.5. Signal intensity as a function of [metHb] 
 
 
Figure 3.7 Signal intensity as a function of metHb concentration for fixed ATP 
concentrations: MetHb solutions of 0.51-256 M were prepared with PSS or ATP standards (A:50 
nM; B:500 nM; C:5000 nM). In each case, 100 L of the luciferase assay solution were added to 100 
L of ATP standards, pH 7.4 at 23°C. The signal intensity was recorded immediately after the initiation of 

































































































3.5.6. Signal intensity as a function of Ht 
 







































































Figure 3.8. Signal intensity as a function of % Ht. A 1% Ht rat erythrocyte suspension in PSS 
was diluted with PSS to prepare suspensions ranging from 0.01 to 0.6% Ht. The luciferase assay solution 
was added to the suspensions in 96 well plates to initialise the assay. A. Linear regression of signal 
intensities of 0-0.1% () and 0.1-1% Ht (). B. Linear regression of signal intensities of 0 to 0.1% Ht 
solutions. C. Linear regression of signal intensities of 0.1-1% Ht solutions. The linear regression of the 0 to 
0.1% Ht suspensions in A was forcasted forward to 1% Ht. N=5  
 
ATP concentrations increase with Ht but show a biphasic plot distribution (Figure 3.8a).  
Below 0.1% Ht, the inner-filter effect of % Ht is negligible as the plot is linear through 
0%. A second linear phase is observed between 0.1 and 1.0% Ht (Figure 3.8c) with a 
lower slope, which suggests constant inner-filter effect in this % Ht region. To correct for 
this inner-filter effect, the signal of suspensions with Ht <0.1% was extrapolated to 1.0% 
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(Figure 3.8a). Based on the extrapolated signal intensity, the ATP concentration of a 1% 
suspension was estimated to be 2.6±0.2-fold higher than measured for rat erythrocytes.  
 
3.5.7. Standard addition 
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Figure 3.9. Determination of ATP in human erythrocyte suspensions by standard 
addition. A fixed volume of erythrocytes suspension in PSS (10 L) was added to ATP standards in PSS 
to obtain a final Ht of 0.25% and 0-400 nM ATP (). The signal was recorded and the x-intercept 
determined using linear regression. The same procedure was repeated for 0.016% (), 0.06.2% (), and 
0.0039% () Ht.  
The signal increases in proportion with the concentration of ATP added to the 
suspensions; this proportionality improves as a function of decreasing Ht (Figure 3.9). 
However, at the Ht evaluated, the R
2
 of the linear regressions curves were above well 
above 0.9 for every suspension (Table 3.3). The x-axis intercept for each Ht, which 
represents the initial concentration of ATP in the erythrocyte suspensions prior to the 
addition of exogenous ATP (60), was scaled to 1% Ht in order to compare them. The 
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initial ATP concentration at 1% Ht was determined to be 1147±205 nM 
(average±S.E.M). 
 
Table 3.3. Approximation of [ATP] of a 1% Ht erythrocyte suspension from x-axis 








0.25 109x +21219 0.9419 194 775 
0.062 147x+9403 0.9929 64 1026 
0.016 210x+3461 0.9987 16.5 1055 




3.6.1. Time course of chemiluminescence decay 
 
For 200 nM ATP, the signal half life was estimated to be 10 min (Figure 3.2).  The decay 
of the light signal is characteristic of a slow decay signal, which can be used to accurately 
measure ATP concentrations in several wells consecutively without dramatic loss of 
signal (61). For each sample, we assay multiple aliquots for improved accuracy and add 
the luciferase assay solution manually to our samples and standards. These aspects of our 
assay compelled us to evaluate the transience of the signal in order to ensure the precision 
of our measurements. In the first 20 s following the initialization of the assay, we 
observed a signal decay of 4% (Figure 3.3), as our data is collected within 10 s of 
initialization, we lose less than 4% of the signal when assaying a sample in quadruplicate. 
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The indeterminate error associated with the assay was found to be 2%; this is 
significantly lower than the sample error which can arise with multiple readings of 
biological samples.  
 
3.6.2. Thermal stability of assay solution 
 
Less than 5% of the signal remained following 20 min preincubation of the assay solution 
at 37°C (Figure 3.4). Despite the significant decrease in signal intensity, the calibration 
curves are linear; it would be feasible to determine the concentration of ATP with assay 
solution pre-incubated at 37°C. An important caveat to this is the necessity to pre-
incubate the assay solution in small aliquots for precisely the same amount of time. While 
it would be ideal to preincubate the luciferin assay solution at the same temperature as 
sample erythrocyte suspensions (37°C), there is a real risk of jeopardizing an experiment 
due to the unyielding time constraints imposed by the rapid, thermal inactivation of 
luciferase (59). 
 
3.6.3. Effect of salt concentration on the chemiluminescence signal intensity 
 
Decreasing the salt concentration relieves quenching of the chemiluminescence signal. 
We observed a 2-fold increase slope of the calibration curve with standards prepared in 
60% PSS and a 10-fold increase for ATP standards prepared in Milli-Q water (Figure 
3.5). Since ATP release from intact erythrocytes depends on the composition of the 
medium (O2 saturation, osmotic strength, etc), it will be critical to ensure that factors 
altering ATP release are not masked by the effects of salt on the assay. Thus, calibration 
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curves must be prepared for every medium used otherwise the concentration of ATP 
measured for a given sample might be in error.  
 
3.6.4. Inner filter effect of Hb on chemiluminescence 
 
Free Hb interferes with the chemiluminescence signal recorded when assaying for ATP 
(29) and as a result, the true concentration of ATP in a Hb solution will be 
underestimated. The plot of signal intensity vs. metHb concentration is biphasic (Figure 
3.7). We attribute the high interference in the low metHb range to signal absorption in the 
bulk solution. At higher metHb concentrations, light is only emitted from the surface, and 
therefore less is absorbed by metHb. However there is attenuation even at very low Hb 
concentrations, when the inner-filter effect should be negligible, which suggests that 
other quenching mechanisms are operative. Therefore the use of cell-free Hb to correct 
for inner-filter effects is not a viable option. Having  
3.6.5. Signal intensity as a function of % Ht 
 
The signal intensity of erythrocyte suspensions of varying Ht were converted to ATP 
concentrations using a standard ATP calibration curve. The signal emitted increased 
linearly with Ht to 0.1%. Above this value, a second linear region was observed with a 
decreased slope (Figure 3.8). As the chemiluminescence signal is robust at Ht at low as 
0.01% Ht, the inner-filter and other matrix effects can be addressed by simply decreasing 
the Ht. Extrapolation of the 0-0.1% Ht plot showed that the ATP concentration of a 1% 
Ht s  uspension will be underestimated by ~3 fold.  Assaying ATP in suspensions at 
44 
 
higher % Ht would more closely mimic physiological conditions and the Ht of an 
erythrocyte suspension could influence cell to cell interactions. Correction factors such as 
these could be used to approximate the ATP concentration in suspensions at higher % Ht.  
 
3.6.6. Standard addition 
 
Untreated, washed erythrocytes in suspension have a basal ATP concentration that was 
measured using the luciferin-luciferase assay. Hb interference can be mitigated by 
diluting the suspensions below 0.1% Ht, and such, we used low % Ht suspensions to 
perform standard addition. Linear regression was used to determine the initial ATP 
concentration in the suspensions and then these were scaled to 1% Ht. The ATP 
concentration for the suspensions scaled to 1% Ht was determined to be in the low 
micromolar range. This raised the question if the ATP released into the medium 
represents all of the ATP present in suspension. In other words, is some of the ATP 
associated with the erythrocyte or is it all freely diffusing in the medium? This issue is 




Measuring ATP release from intact erythrocytes by chemiluminescence has been 
performed for well over 20 years and has provided critical insight into the role of 
erythrocytes as both sensors and effectors of the metabolic needs of tissues (62). While 
there are methodology papers that cover various aspects of the chemiluminescence of 
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ATP detection such as the kinetics of signal decay (61), to our knowledge, there has not 
been such a report for erythrocyte suspensions. The signal emitted by the reaction of ATP 
with a crude firefly lantern extract is both intense and sufficiently persistent to allow for 
replicate readings to be recorded for greater precision. We sought to account for the fact 
that Hb, the major protein component of erythrocytes absorbs strongly in the visible 
region overlapping the chemiluminescence produced by the activity of luciferase.  We 
report that it is possible to correct for the filtering effect of erythrocytes simply by 
decreasing the Ht below 0.1% where the absorbance of the emitted signal does not affect 
the proportionality of the instrument response. 
 Given our findings, we recommend that the luciferase assay solution be at ambient 
temperature, that the assay be performed at 23°C, and that replicate measurements be 
taken for samples if the assay solution being used is a slow decay reagent. Furthermore, 
we recommend that the % Ht be between 0.06% and 0.004%, a range where the Ht is low 
enough to mitigate the interference, but still high enough for there to be a strong signal 
without the need to supplement the assay with synthetic luciferin. Another approach to 
mitigating the filtering effects of Hb on the assay could come from modifying elements 
of the assay system itself. Luciferin has been modified to produce a red-shifted emission. 
This has been accomplished by the addition of an amino-seleno moiety which produces 
an emission with a max of 600 nm (63) or conversely by conjugation to the near IR dye 
Cy5 which has a max of 670 nm (64). Either luciferin analogues could prove to be a 
valuable tool in assaying erythrocyte ATP, as Hb does not absorb as strongly in the 
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The importance of extracellular ATP in the modulation of vascular tone is no longer a 
novel premise.  However, the mechanisms for ATP release from circulating erythrocytes 
remain under investigation. It is difficult to accurately measure ATP in erythrocyte 
suspensions due to Hb’s high absorption. To circumvent this problem, researchers 
measured ATP in erythrocytes at low Ht (<0.1%) or in supernatants. However, it has 
never been demonstrated that comparable results could be obtained working with 
suspensions and supernatants. To determine whether the ATP measured in the 
supernatants provides an accurate measure of the ATP exported from the erythrocytes, 
exposure to CO2, N2, hypo-osmotic stress and NO2
-
 were used to stimulate erythrocyte 
ATP release. Baseline levels of ATP in the supernatant grossly underestimated the 
amount of externalized ATP. For example, the ATP concentration in rat erythrocyte 
suspensions was 10-50x higher than in the supernatants. Furthermore, the ATP 
concentrations determined for rat erythrocytes were consistently higher than for human 
erythrocytes, but human erythrocytes were found to be more sensitive to certain stimuli. 
While ATP can be measured in the supernatants of erythrocyte suspensions, a 
considerable portion remains unreleased and yet still accessible to enzymatic degradation. 
The major implication of this finding is the possibility of two modes of erythrocyte ATP 
release: one where ATP is freely released into the supernatant and another, where it 
remains largely accessible for cellular signaling, but is not consumed unless the 




4.2. Introduction.  
 
In addition to being sensitive local oxygen levels, erythrocytes also act as modulators 
of vascular tone through the release of adenosine triphosphate (ATP) into vessel 
lumen (65).  When extracellular ATP interacts with endothelial receptors it acts as a 
potent vasodilator; increasing blood flow and consequently, oxygen saturation (66). 
Rather than coming from bulk, cytosolic ATP, the ATP that is released into the 
vasculature from erythrocytes is thought to come from discrete pools, such as those 
that are compartmentalized for use by membrane-spanning pumps (20). In fact, 
hypoxia-stimulated release of a fluorescent ATP-analog from these pools has been 
recently reported (67). Our recent examination of inteferents and assay parameters for 
the measurement of ATP in erythrocytes suspensions (Chapter 3), prompted us to 
question whether comparable results would be obtained working with suspensions and 
supernatants. In vitro, erythrocyte-derived ATP has been measured in supernatants (24) 
and suspensions (56) (16), using the luciferin-luciferase chemiluminescence assay but it 
is unknown whether all of the ATP that is externalized by erythrocytes is released and 
freely diffusing in the medium.  In addition to comparing the concentration of ATP 
externalized in suspensions and supernatants, we examined the effects of known 
stimuli of ATP release on the concentrations recorded for erythrocyte suspensions and 
supernatants prepared from human and rat blood samples. The recovery of cells 
following removal of the stimulus was evaluated using sequential centrifugation. We 
report here that the ATP measured in erythrocyte suspensions and supernatants are 
not comparable, and in fact, represent two forms of externalized ATP. In the 
50 
 
supernatant, ATP is freely diffusing, while in suspensions, ATP remains associated 
with the erythrocyte.   
 
4.3. Materials  
 
Adenine triphosphate disodium salt, bovine serum albumin, potato apyrase, firefly lantern 
extract and NaNO2
 
were purchased from Sigma–Aldrich (St. Louis, MO). The suppliers 
of the other chemicals were as follows: KCl from Fisher Scientific, (Pittsburgh, PA); 
CaCl2, MgSO4 from ACP Chemicals, (Montreal, QC); NaCl; tris (hydroxymethyl) 
aminomethane from Bio Basic Inc, (Markham, ON); Hepalean (1,000 U/mL heparin) 
from Organon (Canada), dextrose from Bioshop (Burlington, ON); ultrahigh purity 
nitrogen gas from Praxair (Danbury, CT). Distilled water was purified using a Milli-Q 
Simplicity 185 System from Millipore (Billerica, MA). A Mettler Toledo MX5 
microbalance (Mississauga, On) was used to weighed out all compounds which were 
aliquoted in mg. 
 
Physiological salt solution (PSS) was prepared as follows: 5% v/v tris (hydroxymethyl) 
aminomethane (420 mM), 5% v/v Ringers solution (94 mM KCl, 40 mM CaCl2, 24 mM 
MgSO4, 2810 mM NaCl), 0.2% w/v D-glucose and 0.5% w/v bovine serum albumin.  
The pH was adjusted to 7.4 with 10 N HCl. The PSS was prepared fresh at the beginning 





4.4.1. Luciferin-luciferase assay – assay mixture and standards  
The luciferase assay solution used to quantify ATP was prepared by dissolving firefly 
lantern extract in MilliQ H2O. The solution of 1.3 mg/mL, was mixed by gentle rocking, 
and centrifuged at ambient temperature for 10 min at 3300 g using the IEC GP8R 
centrifuge. The supernatant was decanted into a foil wrapped 15 mL Falcon tube kept at 
room temperature. Aliquots of the assay mixture were poured into a foil covered reservoir 
for use with a multichannel pipettor. A 2.5 mM ATP stock solution was prepared by 
dissolving 6.9 mg of ATP in 5 mL of fresh PSS.  
 
 Aliquots of the stock solution were diluted 1000 fold in PSS to give a 2.5 M solution 
which was then used to prepare standards ranging from 10 to 1.5 M ATP in PSS. Once 
prepared, the ATP standards were kept on ice, and 100 L was aliquoted in quadruplicate 
into white 96 well plates. The chemiluminescence reaction was initiated with the addition 
of 100 L of the assay solution to these standards. The chemiluminescence signal of the 
standards was recorded with a Spectra Max L luminometer, Spectrafluor plus plate reader 
from Molecular Devices (Sunnyvale, California) and the calibration curve generated by 
plotting the signal intensity in relative light units (RLU) of the standards against their 
nanomolar ATP concentrations.   
 
4.4.2. Preparation and assay of erythrocyte samples 
 
Female Wistar rats 375–450 g were housed and anesthetised in adherence with the 
research and teaching guidelines of the CCAC as per the UAREC of Concordia 
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University.  Rats were anesthetised by 1-2 min of inhalation of CO2 (from sublimated dry 
ice) and blood was obtained by cardiac puncture. Using a heparinised needle, a technician 
collected up to 3 mL of whole blood from each animal.  The blood was then transferred 
to 4 mL lithium heparin coated Vacutainer™ brand tubes and kept on ice until 
centrifugation. Rats were restrained, and a small portion (<1 cm) of the animal’s tail was 
removed using a straight razor. Blood flow from the tail was ensured by gentle stroking 
the tail from the base to the tip. Up to 1 mL of whole blood was collected in lithium 
heparin coated BD microtubes by this method. Informed written consent was obtained 
from healthy adult female volunteers, ages 18-30 years of varying ethnicity and fitness 
levels. The collection and use of blood from human volunteers were in accordance with 
the UHREC of Concordia University. Blood was collected into 4 mL heparinised tubes 
by venipuncture from a tourniqueted antecubital vein and kept on ice until centrifugation.  
Within 1 h of blood collection, an aliquot of whole blood was transferred into a 2 mL 
Eppendorf tube and centrifuged in a Micromax RF Thermo IEC at 1700 g for 5 min at 
4°C.  Following centrifugation, the plasma and the fraction containing the white blood 
cells (leukocytes) and platelets were removed by aspiration.  The packed erythrocytes 
were suspended in an equal volume of fresh PSS and then centrifuged as above; the cells 
were washed in this manner two more times.  A small volume of packed erythrocytes was 
removed during the wash steps to ensure that all of the plasma and buffy coat was 






Figure 4.1. Scheme of sequential centrifugation in luciferin-luciferase assay  
 
Sequential centrifugation was employed in order to examine the extent of the interference 
that erythrocytes represent. It also allows us to distinguish the effects of stimuli of ATP 
release on erythrocyte suspensions from the supernatants. The packed cell volume or Ht, 
is the percentage of the total volume that the erythrocytes represent.  
As schematized  in Figure 4.1, 1 mL of 2% Ht suspension was prepared by dispensing 20 
L of isolated erythrocytes into a dolphin tip microcentrifuge tube containing 980 L of 
37°C PSS. The erythrocytes were pre-incubated at this step. The microfuge tube was 
inverted to mix and then placed in the water bath at 37°C for 30 s.  The 2% Ht suspension 
was then dispensed in the plate in four, 50 L aliquots.  To these aliquots, 50 L of fresh 
37°C, PSS was added to bring the Ht of the suspension to 1% in the wells (suspension A 
in Figure 4.1).  The remaining 800 L of original suspension was centrifuged at 1700g 
for 45 s at ambient temperature. Following centrifugation, 100 L of the supernatant was 
aliquoted (supernatant B in Figure 4.1). The remaining supernatant was removed and the 
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packed erythrocytes were suspended in 1584 L of fresh PSS to yield 1600 L of a 1% 
Ht suspension.  From this suspension, four 100 L aliquots were dispensed (solution C in 
Figure 4.1). The remaining 1200 L was centrifuged at 1700g for 45 s at ambient 
temperature. As with supernatant B, 100 L of the supernatant was aliquoted 
(supernatant D in Figure 4.1). For all samples tested, chemiluminescence reaction was 
initiated as before, by the addition of 100 µL of assay solution. A portion of supernatant 
D was used to determine whether the samples had undergone hemolysis using the optical 
density in the visible region. All solutions were aliquoted in quadruplicate in 96 well 
plates. 
4.4.3. Modulation of erythrocyte ATP  
4.4.3.1. Apyrase  
A 27 U/mL stock solution was prepared by dissolving 1 mg of 54 U/mg of apyrase in 2 
mL PSS.  Using this stock solution, a 2% Ht suspension was prepared in 1 mL of PSS 
with a final concentration of 10 U/mg apyrase.  1 U will produce 1.0 μmole Pi/min (from 
ADP or ATP) at pH 6.5 at 30 °C (68). Following a 30 min incubation at 37°C, the 
erythrocyte suspensions and supernatants were assayed as described in section 4.4.  
4.4.3.2. Preincubation with NaNO2 
For the treatment of erythrocytes with NaNO2, a 20 mM stock solution of NaNO2 treated 
PSS was prepared by adding 1.38 mg NaNO2 to 1 mL PSS. The NaNO2 stock solution 
was then diluted serially to obtain 10 mL of a 200 nM NaNO2. Aliquots of 500 L of the 
resulting 200 nM solution were added to 480 L of PSS in 2 mL dolphin tipped 
microfuge tubes and briefly vortexed at high speed. Through the addition of 20 L of 
packed erythrocytes we obtained a 2% Ht in 1 mL containing 100 nM NaNO2. The 
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sample was mixed by inversion and the microfuge tubes were placed in a 37°C water 
bath for 30 s assayed as described in section 4.4. 
4.4.3.3. N2 exposure of erythrocytes  
A total volume of 3 mL of a 2% Ht erythrocyte suspension was prepared and dispensed 
equally into two 20 mL glass vials. One aliquot was left uncapped at room temperature 
and the other was capped with a syringe-fitted septum. A constant supply of N2 at 5 psi 
was delivered through the syringe. A needle was passed through the septum to allow the 
gas in the vial to be expelled. Following 15 min of N2 exposure, 1 mL of the erythrocyte 
suspension was removed, placed in a 2 mL Eppendorf tube and assayed for ATP as 
described in section 4.4.  The time matched control was assayed in the same manner. 
4.4.3.4. Pre-incubation of erythrocytes in hypo-osmotic media 
Packed erythrocytes were submitted to hypotonic stress by suspending 20 L of packed 
erythrocytes in 980 L 60% v/v PSS at 37°C. Following the aliquoting of suspension A 
and supernatant B into the plate, suspension C and supernatant D were obtained 
following the suspension of erythrocytes in 100% PSS, as described in section 4.4. 
 
4.4.4. Data processing and statistical analysis 
Data was processed using Microsoft Office Excel and plotted using Origin Pro 8.1  
(OriginLab, Northampton, MA). Origin Pro 8.1 was also used for the ANOVA statistical 
































Figure 4.2. Distribution of extracellular ATP in erythrocyte suspensions and 
supernatants following 30 s incubation in PSS at 37°C. Erythrocyte suspensions A and C and 
supernatants B and D were prepared as described section 4.4. The error bars denote the standard error of 
the mean (± s.e.m.). Left panel: Female human erythrocytes obtained by venipuncture N=16. Right panel: 
Female Wistar rat erythrocytes obtained by tail bleed. N=14. 
We measured ATP from erythrocytes following sequential centrifugation in order to 
determine whether suspensions and supernatants had comparable ATP concentrations and 
thus evaluate the interference of intact erythrocytes with the signal (Figure 4.2). Free of 
the interference from erythrocytes, the supernatants were expected to have a higher ATP 
concentration than their respective erythrocyte suspensions, providing a more accurate 
measure of the amount of ATP being released from the cells. The concentration of ATP 
in both human and rat erythrocyte suspensions were significantly higher than in their 
respective supernatants. Interestingly, while the ATP concentration of the supernatants of 
rat and human erythrocytes are similar in concentration (human B:15±2.4 nM, D:7.7±2.3 





























erythrocyte suspensions is 10 times higher than those measured in human cells (human 
A:28±4.6 nM, C:34±6.0 nM and rat A:265±50 nM, C:276±43 nM). This disparity gives 
rise to a marked difference in the ratio of measured ATP in the erythrocyte suspensions 
as compared to their respective supernatants; 2-4x in humans and 10-50x in rats. For each 
species, the concentration of ATP measured in suspensions A and C were the same, 
indicating that handling did not produce artefacts in ATP release. 
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Figure 4.3. Distribution of extracellular ATP in Wistar rat erythrocyte suspensions 
and supernatants following 30 min incubation with 10 U apyrase at 37°C. Erythrocyte 
suspensions in A were exposed to 10 U apyrase in PSS; suspensions A and C and supernatants B and D 
were prepared as described section 4.4. Solutions A-D represent erythrocyte suspensions and supernatants 
as described in Figure 4.1.  The error bars denote the standard error of the mean (± s.e.m.). N=4.  
Erythrocytes were incubated with apyrase, an ATP-hydrolyzing enzyme which has been 
used to demonstrate the accessibility of ATP to reagents in solution (3). We also sought 
to determine whether removing the ATPase would restore the ATP concentrations. In 
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suspension A, a decrease of at least 80% was observed relative to the time matched 
control while in supernatant B, the signal was completely extinguished following apyrase 
treatment. When the apyrase treated PSS was removed and the erythrocytes suspended in 
fresh PSS, the ATP concentration was up to 40% higher than the control; however 
solution D was up to 80% lower. Our findings here demonstrate that ATP which is 
accessible to luciferase (without which it would be impossible to determine ATP 
concentrations), is also accessible to apyrase. 
 
4.5.3. Effects of CO2 inhalation on ATP release from erythrocytes 
 
 
Erythrocytes were collected from Wistar rats by tail bleed and/or by cardiac puncture as 
described in section 4.4. Suspensions and supernatants prepared from hypercapnic 
erythrocytes display the same trend as those prepared from normoxic erythrocytes; the 
ATP concentrations measured in the suspensions were considerably higher than their 
supernatants. Also, the concentration in suspensions A and C are not significantly 
different from one another following in vivo exposure to CO2. However, the 
administration of CO2 to Wistar rats prior to blood collection yields extracellular ATP 
concentrations that are close to double those found in blood obtained by tail bleed (A: 



























































Figure 4.4. ATP release from Wistar rat erythrocytes exposed to hypercapnia. 
Erythrocytes from Wistar rats collected by tail bleed (control) or by cardiac puncture following 
hypercapnic euthanasia (CO2) as described in section 4.4. Upper panel. Effects of 2-3 min in vivo exposure 
to hypercapnia on the extracellular ATP concentrations recorded in erythrocyte supernatants and 
suspensions. Lower panel. Normalized ATP concentration of hypercapnic erythrocytes compared to 
erythrocytes collected by tail bleed. A-D represents erythrocyte suspensions and supernatants as described 





In 2008, Faris and Spence determined that two stimuli of ATP release could elicit a 
greater response when used simultaneously (16). Similarly we sought to determine 
whether further ATP release could be stimulated from rat erythrocytes collected 
following CO2 exposure. The addition of NaNO2 to the medium had no effect on the 
extracellular ATP concentrations determined for suspensions and supernatants of cells 
that were exposed to hypercapnia (A: 1.11±0.22, B: 0.90±0.17, C: 0.93±0.14, D: 
1.13±0.27) (data not shown). In addition to hypercapnic erythrocytes, normoxic 
erythrocytes were exposed to 100 nM NaNO2. The erythrocyte suspensions are still 10-
50x higher than their respective supernatants, the same trends that have been observed so 




4.5.4. Effects of NO2
-


























































Figure 4.5 Variation in extracellular ATP following 30 s exposure of Wistar rat 
erythrocytes obtained by tail bleed to NaNO2. Erythrocytes collected from Wistar rats by tail 
bleed, as described in section 4.4, were either incubated with 100 nM NaNO2 (NO2
-
) or left untreated 
(control). Upper panel: Effects of incubation with 100 nM NaNO2 on the recorded extracellular ATP 
concentrations of suspensions and supernatants prepared from erythrocytes collected by tail bleed. Lower 
panel: Normalized extracellular ATP concentration of NaNO2 treated erythrocytes samples compared to 
untreated erythrocyte samples. A-D represent erythrocyte suspensions and supernatants as described in 
Figure 4.1. The error bars denote the standard error of the mean (± s.e.m.). N=5 
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Previous work with human erythrocytes undertaken by our group measured prompt ATP 
release from erythrocytes following treatment with 100 nM NaNO2. Cells were 
centrifuged and re-suspended in untreated PSS prior to measuring ATP (suspension C) 
and a 1.5 fold increase in the extracellular ATP concentration was reported for human 
erythrocytes (4). There was no additional response to the treatment of hypercapnic rat 
erythrocytes with 100 nM NaNO2 and so we evaluated the effect of 100 nM NaNO2 with 
normoxic rat erythrocytes. The relative distribution of ATP between the supernatants and 
suspensions is similar to what we have observed so far (Figure 4.5 top panel).  NaNO2 
exposure did not elicit a substantial change in the normalized ATP concentrations 
measured in solutions A,C and D, however a 30% increase is observed in solution B 





























































Figure 4.6. Hypoxia induced ATP release from human erythrocytes. Erythrocytes 
collected by venipuncture from female human volunteers as described in section 4.4. were stored for 15 
min, either under air (control) or 5 psi N2 gas (hypoxia). Upper panel: Effects of hypoxia on the recorded 
extracellular ATP concentrations of suspensions and supernatants prepared from erythrocytes. Lower 
panel: Normalized extracellular ATP concentration of suspensions and supernatants prepared from hypoxic 
erythrocytes compared to normoxic controls. A-D represents erythrocyte suspensions and supernatants as 
described in Figure 4.1. The error bars denote the standard error of the mean (± s.e.m.). N=9 replicates 
from 6 volunteers 
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Hypoxic conditions generated by deaerating erythrocytes is a well-documented means of 
stimulating ATP release in mammalian erythrocyte suspensions (3). When human 
erythrocyte suspensions were dearated, there was a 40% increase in suspension A and 
supernatant D and an 600% increase in supernatant B (N2:A: 35.26±7.29 nM, B: 
83.48±15.60 nM, C: 29.79±8.57 nM, D: 3.72±1.35 nM; control: A: 32.47±8.12 nM, B: 
13.83±4.64 nM, C: 32.38±6.30 nM, D: 2.43±0.90 nM). The bottom panel of  
Figure 4.6 highlights the significant fold increase in ATP release was observed 
immediately following treatment with N2, but not following centrifugation and 
suspension in fresh media (A: 1.45±0.23; C: 0.94±0.16). The increase in ATP that we 
observed in suspension A is congruent with findings for the hypoxic release of ATP from 
human erythrocytes (4).  Supernatant B showed a considerable increase in measured ATP 
compared to its time matched control. In the case of supernatant D, the increase is 4x less 
than that observed in solution B (B: 8.05±1.68, D: 1.38±0.17). In the research regarding 
ATP release from erythrocytes, the effects of hypoxia have primarily been examined in 
human (3), or New Zealand rabbit erythrocytes (16). We had found the scarcity of data 
on rat erythrocytes curious given their ubiquity in drug development and research.  The 
exposure of Wistar rat erythrocytes to 15 min of N2 gas at 5 psi did not affect the trend 
seen with erythrocyte suspensions and supernatants, with the notable exception of 
supernatant B (N2: A: 40.2±7.6, B: 29.3±1.9, C: 50.5±6.1, D: 0.53±0.30; control: A: 
45.0±11.1, B: 4.7±0.8 C: 42.1±6.9, D: 0.41±0.21).  Normalization reveals that deaeration 
did not significantly increase ATP concentrations in the suspensions (A:1.13±0.40, 
C:1.34±0.33). As with human erythrocytes, only supernatants B showed a considerable 

























































Figure 4.7 Hypoxia induced ATP release from Wistar rat erythrocytes.  Erythrocytes 
from Wistar rats were collected by tail bleed as described in section 4.4. were stored for 15 min, either 
under air (control) or 5 psi N2 gas (hypoxia). Upper panel: Effects of hypoxia on the recorded extracellular 
ATP concentrations of suspensions and supernatants prepared from erythrocytes. Lower panel: Normalized 
extracellular ATP concentration of suspensions and supernatants prepared from hypoxic erythrocytes 
compared to normoxic controls. A-D represents erythrocyte suspensions and supernatants as described in 




We observed an increase in extracellular ATP concentrations measured in suspension A 
and supernatants B and D prepared from hypoxic human cells, compared to control. From 
the rat preparations, only in supernatant B did we observe a significant increase in 
measured ATP. Human erythrocytes released more ATP into supernatant B than did 
erythrocytes obtained from rat. Human cells appear to be more sensitive to hypoxia that 
rat cells which might be related to the disparities between the two mammals’ circulatory 
systems.  
 
4.5.6. The effects of hypo-osmotic stress (40% osmotic downshift) on ATP 
release from erythrocytes 
 
Experimentally, osmotic stress has been used as a model for shear stress, a known 
stimulus of ATP release from erythrocytes (24). A 40% downshift in osmolarity was used 
as a means of stimulating ATP release in suspension A and supernatant B, and the 
erythrocytes were suspended in an isotonic solution in suspension C and supernatant D, 
as described in the section 4.3.3. Osmotic downshifts, which induce swelling, a form of 


























































Figure 4.8. Variation in extracellular ATP following 30 s exposure to a 40% osmotic 
down shift of Wistar rat erythrocytes Erythrocytes from Wistar rats were collected by tail bleed 
as described in section 4.4. Upper panel: Effects of a 40% osmotic downshift on the recorded extracellular 
ATP concentrations of suspensions and supernatants prepared from Wistar rat erythrocytes. Lower panel: 
Normalized extracellular ATP concentration of suspensions and supernatants prepared from Erythrocytes in 
solution A were suspended in 60% PSS. Solutions A-D represent erythrocyte suspensions and supernatants 
as described in Figure 4.1.  The error bars denote the standard error of the mean (± s.e.m.). N=9 
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A 40% downshift caused a spike in ATP in both suspension A and supernatant B, which 
is not observed in suspension C and supernatant D following a return to isotonic media 
(Figure 4.8 top panel. Control:A: 253.91±54.7 nM, B: 24.2±8.4 nM, C: 274.3±56.8 nM, 
D: 6.2±1.7 nM, osmotic stress: A: 1633.5±520.5 nM, B: 55.2±13.8 nM, C: 418.32±175.0 
nM, D: 4.7±1.3 nM). The fold difference in ATP concentrations measured in solution A 
and B following osmotic downshift was significantly higher than the control (Figure 4.8 
bottom panel. A: 5.1±0.9; B: 3.3±0.9). The increase in the latter solution is in line with 
results obtained under similar conditions by the Locovei lab group (24). When these 
erythrocytes were then suspended in isotonic PSS, there was not a significant fold 
increase in measured ATP concentrations (Figure 4.8 bottom panel. C: 1.39±0.50; D: 
1.01±0.23).  
As with the rat erythrocytes, in suspension A and supernatant B of the downshifted 
human erythrocyte, an immediate, significant increase in measured ATP concentrations 
was observed, while in solution C and D, the concentrations of ATP determined return to 
control levels (Figure 4.9 top panel. control:A: 13.83±1.23 nM, B: 7.2±2.8 nM, C: 
27.2±2.6 nM, D: 1.56±0.44 nM. osmotic stress: A: 1733.0±213.5 nM, B: 25.7±11.9 nM, 
C: 40.1±16.5 nM, D: 1.9±1.1 nM). The trend in ATP for solution A-D from human 
erythrocytes is similar to rats, even if the fold increase is not (Figure 4.9 bottom panel. A: 
132.5±22.1, B: 6.2±2.7, C: 1.6±0.7, D: 1.3±0.38). Human erythrocyte solution A released 
comparable levels of externalized ATP than rat erythrocytes. However, while the increase 
in suspension A for rat erythrocytes is ~5 fold, it is 100 fold in human erythrocytes. Like 
rat erythrocytes, the increase in ATP release observed in humans erythrocytes for 
supernatant B is congruent with previously reported findings (24). Following 
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centrifugation and suspension in fresh media, the extracellular ATP concentrations are 
not significantly different than the control values. It is important to note that two standard 
curves were used to quantify ATP from suspensions and supernatants exposure to an 
osmotic downshift. For suspension A and supernatant B, the standards were prepared in 
60% PSS; for suspension C and supernatant D, the standards were prepared in 100% PSS. 
Two standard curves were used because the ion concentration of the media influences the 
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Figure 4.9. Variation in extracellular ATP following 30 second exposure to a 40% 
osmotic down shift of human erythrocytes obtained by venipuncture.  Erythrocytes from 
female human volunteers were collected by venipuncture as described in section 4.4. Upper panel: Effects 
of a 40% osmotic downshift on the recorded extracellular ATP concentrations of suspensions and 
supernatants prepared from Wistar rat erythrocytes. Lower panel: Normalized extracellular ATP 
concentration of suspensions and supernatants prepared from Erythrocytes in solution A were suspended in 
60% PSS. Solutions A-D represent erythrocyte suspensions and supernatants as described in Figure 4.1.  




4.6. Discussion  
 
We had anticipated that the ATP concentrations in the supernatants would be higher than 
in the suspensions due to the inner-filter effect observed by our group previously 
(Chapter 3). The elevated concentration of ATP in the suspensions as compared to their 
supernatants is indicative of ATP being externalized without being released into the 
supernatant (Figure 4.1). However, this ATP remains accessible to react with 
extracellular proteins including luciferase, without which there would not have been a 
measurable signal. This externalized ATP is also accessible to apyrase, an exogenous 
ATPase which was used to further probe the extracellular nature of the ATP measured in 
suspensions and supernatants. An incubation with 10 U of apyrase completely abolished 
the signal measured in suspension A and supernatant B and following its removal the 
signal was restored to control values in suspension C and supernatant D ( 
Figure 4.2). The release of ATP from erythrocytes into the vascular lumen has to be 
carefully controlled due to its potency as a vasodilator. It is possible that the ATP 
measured in erythrocyte suspensions is associated with the membrane through the 
proteins that have been reported to be involved with its release such as pannexin-1 (24) or 
the cystic fibrosis transmembrane conductance regulator (CFTR) (31) (23) in order to 
regulate access to it. The disparity between erythrocyte suspensions and supernatants 
reveals that both solutions can be highly informative and that there might be distinct 
mechanisms regulating ATP’s externalization to the erythrocyte as oppose to the 
circulation. Sequential centrifugation brought to light an intriguing aspect of the 
localisation of ATP in erythrocyte suspensions and established the importance of 
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continuing to evaluate the ATP concentration of erythrocyte suspensions, in spite of their 
inherent filtering effect. It is important to note that the maximum hemolysis observed 
throughout the course of this work was 2.1% (A410=0.35), which is congruent with a 
literature value for spontaneous hemolysis of 1% (3).  
 
The extensive loss of signal in suspension A and solution B in the presence of apyrase 
demonstrates that it is possible to hydrolyse both the ATP that is associated with 
erythrocytes as well as the ATP in the supernatant with apyrase. When treated with 
apyrase, treatment of the suspensions with apyrase led to 80% loss of their ATP signal 
and no ATP was detected in their supernatants (Figure 4.3). We have also observed a 
novel phenomenon by which the ATP that is measured in the erythrocyte solutions is 
restored following hydrolysis by apyrase and the removal of the ATPase. This 
observation highlights the importance of the erythrocyte-associated ATP in rat 
erythrocytes: ATP concentrations in supernatant C were consistently restored to 
concentrations equal or greater to those initially observed in the control. Apyrase has 
been used previously to establish whether the ATP measured in the erythrocyte solutions 
was actually extracellular (3). We confirm that the ATP measured in the suspensions is 
externalized and accessible to apyrase. The treatment of erythrocytes with apyrase should 
most definitely be done with human cells. We know that humans have lower levels of 
ATP in their suspensions, and this could probe the relative importance of ATP from 
suspensions as compared to from supernatants. 
Bergfeld and Forrester, examined the effects of hypoxia and hypercapnia on ATP release 
from human erythrocytes (3). The opportunity presented itself in our study to examine the 
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effects of hypercapnia alone on the modulation of ATP release from erythrocytes since 
CO2 was used as a means of euthanizing Wistar rats. Hypercapnia along with hypoxia has 
been demonstrated to elicit ATP release from human erythrocytes (3). We evaluated the 
effect of hypercapnic asphyxiation of Wistar rats by CO2 inhalation and observed a 2 fold 
increase in all of the suspensions and supernatants that were assayed compared to the 
control samples obtained by tail bleed (Figure 4.4). CO2, which is a metabolic waste 
product, is also a potent vasodilator (69). The response that we observe is in line with 
CO2’s role as a vasodilator which has been documented as potentiating dilation of vessels 
in the presence of oxygen (70).  The precise mechanisms of ATP release in response to 
either NO2
-
 or hypercapnia are unknown.  
The addition of NO2
- 
ex vivo to erythrocytes that were exposed to hypercapnia in vivo did 
not increase the amount of ATP released from erythrocytes and only stimulated ATP 
release from supernatant B in normoxic erythrocytes (Figure 4.5). Previous work 
involving the stimulation of ATP from erythrocytes by NO2
- 
used elevated concentrations 
and prolonged (>30 min) exposure times (72) (15). Similar lengthy incubations of human 
erythrocytes were shown to inhibit ATP release from erythrocytes (4). When 
experimental conditions similar to our own were used with human erythrocytes, the 
nanomolar ATP concentration of suspension C was 1.5 fold higher following 30 s 
exposure to 100 nM NO2
-
 (4). Mammalian plasma NO2
-
 concentrations, irrespective of 
whether collected from the venous or arterial circulation, are in a comparable range 
(ie.10
2
 nanomolar) (12). This tight regulation of plasma NO2
-
 concentrations in mammals 
is why we opted to use the same concentration of NO2
-
 that had been effective with 
human erythrocytes for our ex vivo incubations in a physiologically relevant timeframe.  
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The limited effect of NO2
-
 on rat erythrocyte suspensions might be due to the difference 
between rat and human Hbs (72). Namely, it has been shown that rat erythrocye Hb has 
two cysteine residues that serve to detoxify the cell that are not present in human Hb (72). 
It is a distinct possibility that the additional detoxifying capacity of rat Hb is the reason 
that supraphysiological conditions of NO2
-
 have been required to observe a significant 
increase in the ATP concentrations measured in erythrocyte suspensions in other work 
(15). 
Given that CO2 stabilizes deoxyHb and can drive O2 away from Hb (22) it is curious that 
hypoxia, which increases the relative concentration of deoxyHb, did not yield increases in 
ATP concentrations from rat erythrocytes suspensions comparable to those observed 
following hypercapnic asphyxiation. It has been demonstrated that the conformation of 
Hb is more directly correlated with ATP release than oxygenation state (with the T state 
favouring ATP release) (73), however it is worth noting that those experiments were 
performed in the presence of 5% CO2. Our observations are indicative of a role for CO2 
in potentiating ATP release and this would be congruent with findings in the medical 
profession, where it has been recognized that carbogen, oxygen containing 5% of CO2, 
increases blood flow and is more effective in oxygenating tissues than oxygen alone (70). 
The same order of magnitude of extracellular ATP following osmotic downshift was 
measured in suspension A for human and rat erythrocytes (Human: 1733.0±213.5 nM, 
rat: 1633.5±520.5 nM) (top panel of Figure 4.8 and Figure 4.9). However, the relative 
amount of ATP in response to the 40% osmotic downshift compared to control values is 
significantly higher for suspension A in humans than in rats (human: 132.53±22.10, rat: 
5.07±0.19). Similarly, the fold increase in supernatant B is greater in human than in rats 
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(human: 6.24±2.73, rat 3.33±0.87), despite rat erythrocytes releasing more ATP (human: 
25.66±11.92, rat: 55.25±13.82) (top panel of Figure 4.8 and Figure 4.9). Extracellular 
ATP has been shown to play a role in the recovery of cell volume in response to an 
osmotic downshift. This response is in part mediated by increasing the permeability of 
chloride of the membrane (74). Furthermore, the presence of apyrase was shown to limit 
the recovery of cell volume in rat hepatocytes (74). Humans cells appear to be more 
sensitive to osmotic downshifts despite human and rat erythrocytes having similar 




Overall, the concentration of ATP measured in the erythrocyte suspensions A and C 
tended to be far greater than in their respective supernatants B and D, and this regardless 
of species.  These findings are indicative the efficiency of the erythrocytes in managing 
ATP, which is a vital metabolite. In absence of stimuli of ATP release, the majority of 
ATP is externalized without being released into the vessel lumen and lost. Instead, only a 
small portion of the ATP is released to serve as signalling molecule. When the 
erythrocytes are exposed to stimuli of ATP release, the concentration of ATP available 
for release or for interaction with purinergic receptors is increased. Further investigation 
is required to distinguish the role of ATP that can be released into the supernatant (ie. 
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5. General Conclusions and Suggestions for Future Work 
 
5.1. Conclusions 
5.1.1. Chapter 2 
To better understand the mechanism of stimulated ATP release from erythrocytes, we 
tested metHb stabilizing ligands. The rationale being that given metHb’s high affinity 
for the erythrocyte membrane and that membrane bound Hb can signal ATP release, 
these ligands should stimulate ATP release from erythrocytes. The ATP 
concentrations of human erythrocyte suspensions were determined to be in the low 
micromolar range, for all ligands, as well as for the control samples. This finding is 
not in agreement with current literature with regards to stimulated ATP release from 
human erythrocytes, which places the ATP concentration for human erythrocyte 
suspensions in the low nanomolar range (75) (4). While it is possible that hemolysis 
played a role in these elevated values, our findings in Chapter 4 have brought to light 
other factors which might have contributed to elevated ATP concentrations: osmotic 
stress.  
 
Given the availability of an abundance of rodent blood, we sought to simplify the 
incubation process for the NaNO2 stimulated release of ATP from erythrocytes as 
well as troubleshoot the assay as required. Exposure of rat erythrocytes to NaNO2 
appeared to depress ATP release and there was a notable downward trend in replicate 
aliquots. This downward trend had raised concerns with regards to the kinetics of the 
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assay and prompted a more complete evaluation of the luciferin-luciferase assay for 
ATP as used for intact erythrocyte suspensions detailed in Chapter 3.  
 
5.1.2. Chapter 3 
The linearity of the ATP standard curves was not affected by a change in ion 
concentration or the presence of Hb. However, the signal intensity was decreased as a 
function of both increasing ion and Hb concentrations. The chemiluminescence signal 
from erythrocyte suspensions and ATP treated Hb are bimodal as a function of Ht and 
Hb concentration respectively. The shape of the curves are indicative of a filtering 
effect which might be mitigated in part by the encapsulation of Hb by the erythrocyte 
membrane. Ultimately, working at low Ht  can help limit the erythrocytes’ interference 
in the measurement of their extracellular ATP by chemiluminescence, but a certain 
degree of attenuation still occurs. Even with attenuation, the ATP concentration 
determined for erythrocyte suspensions increased as a function of Ht, which led to the 
hypothesis that some of the ATP may be associated with the erythrocytes.  
 
5.1.3. Chapter 4 
The ATP concentration determined for erythrocyte suspensions was found to be 
considerably higher than for their supernatants in both human and rat samples. 
Untreated human erythrocytes had lower ATP concentrations in their suspensions and 
similar ATP concentrations in their supernatants as compared to rat erythrocytes. The 
ATP in suspensions and supernatants were accessible to both luciferase, without 
which the assay would not be possible, and apyrase. In addition, apyrase provided the 
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first example of the strength of sequential centrifugation as a tool to probe the 
recovery of the erythrocytes following treatment. In the presence of apyrase, the 
signal from ATP was significantly decreased, if not extinguished, whereas when 
apyrase was removed, the levels ATP were restored. Hypercapnia was the only 
stimulus that affected all of the suspensions and the supernatants for rat erythrocytes. 
Otherwise, we found that rat erythrocyte suspensions are not sensitive to 
physiologically relevant concentrations of NaNO2. Also, erythrocytes externalize 
ATP in response to hypo-osmotic stress. In the end, the difference between ATP 
concentrations measured in suspensions and supernatants was surprising given that 
we expected the presence of erythrocytes to attenuate the signal as compared to the 
supernatant. This finding indicates that of the ATP externalized by the erythrocyte, 
only a portion would be released into the circulation, effectively conserving one of 
the cells valuable metabolites. 
 
 
5.2. Future work 
5.2.1. Chapter 2 
The effect of metHb stabilizing ligands on ATP release from erythrocytes should be 
revisited. Understanding whether metHb can play a role in vasodilation could help 
inform the development of vasoactive compounds that can improve oxygen delivery 
by stabilizing metHb. While elevated metHb concentrations can cause cyanosis, in 
certain emergency medical situations, there can be a trade-off between low-grade 




5.2.2. Chapter 3 
Standard addition and the signal intensity as a function of %Ht were performed with 
rat and human erythrocytes respectively. The experiments should be reproduced with 
erythrocytes from both species. Furthermore, the Hb used in the experiments was 
bovine in origin and given that human and bovine Hb do not have the same affinity 
for ATP (76), it could be of interest to obtain human Hb for the evaluation of signal 
intensity as a function of Hb concentration for fixed ATP concentrations. The 
importance of the erythrocyte membrane in limiting Hb’s quenching of the 
chemiluminescence signal should also be investigated using erythrocyte ghosts to 
encapsulate Hb in solution. 
 
 
5.2.3. Chapter 4 
There remains a broad range of potential stimuli that can be examined using 
sequential centrifugation. Including hyper-osmotic stress, which causes cell 
shrinkage, in addition to using a physiological range  of osmotic shifts (<230 or >350 
mOsm/L) would allow us to examine the sensitivity of erythrocytes the different ion 
concentration that could be encountered in individuals with varying degrees of renal 
problems, providing potential insight into the role that erythrocyte ATP might play in 
co-morbidities (77). That being said, I believe that the next step for this work would 
be to determine whether the same measurements can be taken using whole blood. 
Erythrocyte ATP is a known vasodilator and impaired ATP release from erythrocytes 
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has been associated with the vascular pathologies of diseases such as primary 
pulmonary hypertension (32). Being able to streamline the ATP assay using whole 
blood would facilitate the use of ATP as a metric of vascular health. The assay would 
then require a smaller volume of blood, ideally that could be obtained via a simple 





1. U.S. National Library of Medicine. RBC count. MedlinePlus. [Online] 01 25, 2011. 
[Cited: August 11, 2012.] 
http://www.nlm.nih.gov/medlineplus/ency/article/003644.htm#Normal%20Values. 
2. Insulin Inhibits Low Oxygen-Induced ATP Release from Human Erythrocytes: 
Implication for Vascular Control. Hanson, M S., et al. 2009, Microcirculation, Vol. 16, 
pp. 424-433. 
3. Release of ATP from human erythrocytes in response to a brief period of hypoxia and 
hypercapnia. Bergfeld, G R. and Forrester, T. 1992, Cardiovascular Research, Vol. 26, 
pp. 40-47. 
4. Nitrite and nitroglycerin induce rapid release of the vasodilator ATP from 
erythrocytes. Garcia, J I., et al. 2010, Journal of Inorganic Biochemistry, Vol. 104, pp. 
289-296. 
5. The red blood cell as an oxygen sensor: what is the evidence? Ellsworth, M L. 2000, 
Acta Physiologica Scandinavica, Vol. 168, pp. 551-559. 
6. Red blood cell regulation of microvascular tone through adenosine triphosphate. 
Dietrich, H H., et al. 2000, American Journal of Physiology Heart and Circulatory 
Physiology, Vol. 278, pp. H1294-H1298. 
7. Conducted vascular responses: communication across the capillary bed. Collins, D 
M., McCullough, W T. and Ellsworth, M L. 1998, Microvascukar Research, Vol. 56, 
pp. 43-53. 
8. Ideas about control of skeletal and cardiac muscle blood flow (1876-2003): cycles of 
revision and new vision. Rowell, L B. Journal of Applied Physiology, Vol. 97, pp. 384-
392. 
9. Maximal perfusion of skeletal muscle in man. Andersen, P. and Saltin, B. 1985, 
Journal of Physiology , Vol. 366, pp. 233-249. 
10. The Effects of Nitric Oxide on Red Cell Development and Phenotype. Čokić, V P. 
and Schechter, A N. Current Topics in Developmental Biology. 2008, Vol. 82, pp. 169-
215. 
11. Klabunde, R E. Nitric Oxide. Cardiovascular physiology concepts. [Online] 09 23, 
2008. [Cited: August 11 2012.] 
http://www.cvphysiology.com/Blood%20Flow/BF011.htm. 
12. Plasma nitrite reflects consitutive nitric oxide activity in mammals. Kleinbongard, 
P., et al. 2003, Free Radical Biology & Medicine, Vol. 35, pp. 790-796. 
83 
 
13. Erythrocytes are the major intravascular storage sites of nitrite in human blood. 
Dejam, A., et al. 2005, Blood, Vol. 106, pp. 734-739. 
14. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human 
circulation. Cosby, K., et al. 2003, Nature Medicine, Vol. 9, pp. 1498-1505. 
15. Nitrite enhances RBC hypoxic ATP synthesis and the release of ATP into the 
vasculature: a new mechanism for nitrite-induced vasodilation. Cao, Z., et al. 2009, 
American Journal Physiology Heart and Circulatory Physiology, Vol. 297, pp. 1494-
1503. 
16. Measuring the simultaneous effects of hypoxia and deformation on ATP release from 
erythrocytes. Faris, A. and Spence, D M. 2008, The Analyst, Vol. 133, pp. 678-682. 
17. Role of erythrocyte in regulating local O2 delivery mediated by hemoglobin 
oxygenation. Jagger, J E., et al. 2001, American Journal of Physiology Heart and 
Circulatory Physiology, Vol. 28, pp. H2833-H2839. 
18. Characterization of the deoxyhemoglobin binding site on human erythrocyte band 3: 
implications for O2 regulation of erythrocyte properties. Chu, H., et al. 2008, Blood, 
Vol. 111, pp. 932-938. 
19. Hypoxia limits antioxidant capacity in red blood cells by altering glycolytic pathway 
dominance. Rogers, Stephen C., et al. 2009, The FASEB Journal, Vol. 23, pp. 1-12. 
20. On the functional use of the membrane compartmentalized pool of ATP by the Na+ 
and Ca++ pumps in human red blood cell ghosts. Hoffman, J F., Dodson, A. and 
Proverbio, F. 2009, Journal of General Physiology, Vol. 134, pp. 4351-4361. 
21. On the peripheral and central chemoreception and control of breathing: an emerging 
role of ATP. Gourine, A V. 2005, Journal of Physiology, Vol. 568, pp. 715-724. 
22. Effect of carbon dioxide on human hemoglobin. Salhany, J M. 1972 , The Journal of 
Biological Chemistry, Vol. 257, pp. 3799-3801. 
23. Deformation Induced ATP release from red blood cells requires CFTR activation. 
Sprague, R S., et al. 1998, American Journal of Physiology Heart and Circulatory 
Physiology, Vol. 275, pp. H1726–H1732. 
24. Pannexin 1 in erythrocytes: Function without a gap. Locovei, S., Bao, L. and Dahl, 
G. 2006, Proceedings Of The National Academy Of Sciences, Vol. 103, pp. 7655–7659. 
25. Extracellular ATP stimulates volume decrease in Necturus red blood cells. Light, D 
B., et al. 1999, American Journal of Physiology, Vol. 3, pp. 480-491. 
84 
 
26. Prostacyclin Receptor-Mediated ATP Release from Erythrocytes Requires the 
Voltage-Dependent Anion Channel (VDAC). Sridharan, M., et al. 2011, American 
Journal of Physiology Heart and Circulatory Physiology, p. In press. 
27. Spectral emission and quantum yield of firefly bioluminescence. Seliger, H H and 
McElroy, W D. 1960, Archives of Biochemistry and Biophysics, Vol. 88, p. 136. 
28. Nucleoside triphosphate specificity of firefly luciferase . Moyer, J D. and 
Henderson, J F. 1983, Analytical Biochemistry, Vol. 131, pp. 187-189 . 
29. Haemoglobin interferes with the ex vivo luciferase luminescence assay. Colin, M., et 
al. 2000, Gene Therapy, Vol. 7, pp. 1333–1336. 
30. Assessment of ionic quenching onsoil ATP bioluminescence reaction. Wen, G., et al. 
2001, Soil Biology and Biochemistry, Vol. 33. 
31. Cystic Fibrosis Transmembrane Conductance Regulator Facilitates ATP Release by 
Stimulating a Separate ATP Release Channel for Autocrine Control of Cell Volume 
Regulation. Braunstein, G M., et al. 2001, Journal of Biological Chemistry, Vol. 276, 
pp. 6621-6630. 
32. Impaired release of ATP from red blood cells of humans with primary pulmonary 
hypertension. Sprague, R S., et al. 2001, Experimental Biology and Medicine, Vol. 226, 
pp. 434-439. 
33. An altered oxidant defense system in red blood cells affects their ability to release 
nitric oxide-stimulating ATP. Carroll, J., et al. 2006, Molecular Biosystems, Vol. 2, pp. 
305-311. 
34. Chemical physiology of blood flow regulation by red blood cells: the role of nitric 
oxide and s-nitrosohemoglobin. Singel, D J. and Stamler, J S. 2005, Annual Review of 
Physiology, Vol. 67, pp. 99-145. 
35. Catalytic generation of N2O3 by the concerted nitrite reducatase and anhydrase 
activity of hemoglobin. Basu, S., et al. 2007, Nature Chemical Biology, Vol. 3, pp. 785-
794. 
36. Mitochondrial aldehyde dehydrogenase mediates vasodilator responses of glyceryl 
trinitrate and sodium nitrite in the pulmonary vascular bed of the rat. Badejo Jr, A M., 
et al. 2010, American Journal of Physiology Heart and Circulatory Physiology l, Vol. 
299, pp. H819-826. 
37. A hypothesis on the metabolism of glyceryl trinitrate in vascular endothelial cells. 
Tian, Y., et al. 2001, Clinica Chimica Acta, Vol. 313, pp. 51-57. 
85 
 
38. Methemoglobinemia from intravenous nitroglycerin: a word of caution. Bojar, R M., 
et al. 1987, Annals of Thoracic Surgery, Vol. 43, pp. 332-334. 
39. Association of methemoglobinemia and intravenous nitroglycerin adminstration. 
Kaplan, K J., et al. 1985, American Journal of Cardiology, Vol. 55, pp. 181-183. 
40. Nitrite uptake and metabolism and oxidant stress in erythrocytes. May, J M., et al. 
2000, American Journal of Physiology - Cell Physiology, Vol. 279, pp. 1946-1954. 
41. In vivo studies on methemoglobin formation by sodium nitrite. Imaizumi, K., et al. 
1980, International Archives of  Occupational and Environmental Health, Vol. 45, pp. 
97-104. 
42. Pharmacokinetics of sodium nitrite-induced methemoglobinemia in the rat. Kohn, M 
C., et al. 2002, Drug metabolism and disposition, Vol. 30, pp. 676-683. 
43. Characterisation of erythrocytic uptake and release and disposition pathways of 
nitrite, nitrate, methemoglobin and iron-nitrosyl hemoglobin in the human circulation. 
Hon, Y Y., et al. 2010, Drug metabolism and  disposition, Vol. 38, pp. 1707-1713. 
44. The magnetic properties and structure of ferrihemoglobin (methemoglobin) and some 
of its compounds. Coryell, C D., Stitt, F. and Pauling, L. 1937, Journal of the American 
Chemical Society, Vol. 59, pp. 633-642. 
45. Fluoride produces endothelium-dependent relaxation and endothelium-independent 
contraction in coronary arteries. Cushing, D J., et al. 1990, Journal of Pharmacology 
and Experimental Therapy, Vol. 254, pp. 28-32. 





-ATPase. Qamirani, E., et al. 2006, American Journal of 
Physiology Heart and Circulatory Physiology, Vol. 290, pp. H1617-1623. 
47. National Institute for Occupational Safety and Health. Emergency Response 
Card. Centers of Disease Control. [Online] May 12, 2011. [Cited: July 23, 2012.] 
http://www.cdc.gov/niosh/ershdb/PrintableERC_29750038.html. 
48. Antonini, E and Brunori, M. Hemoglobin And Myoglobin In Their Reactions With 
Ligands. New York : Elsevier, 1971. p. 18. 
49. An electron paramagnetic resonance study of the affinity of nitrite for 
methemoglobin. Goetz, Bradley I., et al. 2010, Nitric Oxide, Vol. 22, pp. 149-154. 
50. Sigma-Aldrich - Catalog Product Detail. Sigma-Aldrich Canada. [Online] [Cited: 
August 11, 2012.] http://www.sigmaaldrich.com. 
86 
 
51. Osmolality of mammalian blood and of media for culture of mammalian cells. 
Waymouth, C. 1970, In Vitro, Vol. 2, pp. 109-127. 
52. P2 receptors in cardiovascular regulation and disease. Erlinge, D and Burnstock, 
G. 2008, Purinergic Signalling, Vol. 4, pp. 1-20. 
53. Local control of blood pressure by purines. Burnstock, G. 1987, Blood Vessels, Vol. 
24, pp. 156-160. 
54. The energy source for bioluminescence in isolated systems. McElroy, W D. 1947, 
Proceedings Of The National Academy Of Sciences, Vol. 342. 
55. Membrane Proteins of Incubated Erythrocytes: Effects of Sulphydryl Inhibition. Zail, 
S S. and Van Den Hoek, A K. 1977, British Journal of Haematology, Vol. 37, pp. 353-
361. 
56. Lactate interferes with ATP release from red blood cells. Rozier, M D., Zata, V J. 
and Ellsworth, M L. 2007, American Journal of Physiology Heart  and Circulatory 
Physiology , Vol. 292, pp. H3038–H3042. 
57. Ionic Effects on Firefly Bioluminescence Assay of Red Blood Cell ATP. Aledort, L 
M., Weed, R I. and Troup, S B. 1966, Analytical Biochemistry, Vol. 17, pp. 268-277. 
58. Sigma Aldrich. Firefly lantern extract Catalog Product listing. Sigma-Aldrich 
Canada. [Online] [Cited: August 14, 2012.] 
http://www.sigmaaldrich.com/catalog/product/sigma/fle250?lang=en&region=CA. 
59. The bioluminescent detection of platelet released ATP, collagen-induced release and 
potential errors. Soslau, G. and Parker, J. 1991, Thrombosis, Vol. 66, pp. 15-21. 
60. Harris, D C. Quantitative Chemical Analysis 7th Edition. China Lake : W.H. 
Freeman & Company, 2006. p. 1008. 
61. Use of Firefly Luciferase in ATP-Related Assays of Biomass, Enzymes, and 
Metabolites. Lundin, A. Methods in Enzymology. 2000, Vol. 305, pp. 346-370. 
62. Erythrocytes: Oxygen Sensors and Modulators of Vascular Tone. Ellsworth, M L., et 
al. 2009, Physiology, Vol. 24, pp. 107-116. 
63. A Selenium Analogue of Firefly d-Luciferin with Red-Shifted Bioluminescence 
Emission. Conley, N R., et al. 2012, Angewandte Chemie International Edition, Vol. 51. 
64. Aminoluciferins as functional bioluminogenic substrates of firefly luciferase. 
Takakura, H., et al. 2011, Chemistry, Vol. 6, pp. 1800-1810. 
87 
 
65. Erythrocytes: Oxygen Sensors and Modulators of Vascular Tone. Ellsworth, M L., et 
al. 2009, Physiology, Vol. 24, pp. 107-116. 
66. P2 receptors in cardiovascular regulation and disease. Erlinge, D. and Burnstock, 
G. 2008, Purinergic Signalling, Vol. 4, pp. 1-20. 
67. Identification of cytoskeletal elements enclosing the ATP pools that fuel human red 
blood cell membrane cation pumps. Chu, H., et al. 2012, Proceedings Of The National 
Academy Of Sciences. Vol 109, pp 12794-12799. 
68. Sigma Aldrich. Potato Apyrase Product Catalog listing. Sigma Aldrich. [Online] 
Sigma Aldrich, 2012. [Cited: July 10, 2012.] 
http://www.sigmaaldrich.com/catalog/product/sigma/a6535?lang=en&region=CA. 
69. Enhanced catheter propagation with hypercapnia during superselective cerebral 
catherisaton. Djurberg, H G., Tjan, G T. and Al Moutaery, K R. 1998, 
Neuroradiology, Vol. 40, pp. 466-468. 
70. Carbogen inhalation increases oxygen transport to hypoperfused brain tissue in 
patients with occlusive carotid artery disease: increased oxygen transport to 
hypoperfused br. Ashkanian, M., et al. 2009, Brain Research, Vol. 1304, pp. 90-95. 
71. Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. 
Crawford, J H., et al. 2006, Blood, Vol. 107, pp. 566-574. 
72. Highly Reactive Cysteine Residues in Rodent Hemoglobins. Miranda, J J. 2000, 
Biochemical and Biophysical Research Communications , Vol. 275, pp. 517–523. 
73. Role of erythrocyte in regulating local O2 delivery mediated by hemoglobin 
oxygenation. Jagger, J E., et al. 2001, American Journal of Physiology Heart Circulatory 
Physiology, Vol. 28, pp. H2833-H2839. 
74. Autocrine signaling through ATP release represents a novel mechanism for cell 
volume regulation. Wang, Y., et al. 1996, Proceedings Of The National Academy Of 
Sciences, Vol. 93, pp. 12020-12025. 
75. Metal-activated C-peptide facilitates glucose clearance and the release of a nitric 
oxide stimulus via the GLUT1 transporter. Meyer, J., et al. 2008, Diabetologia, Vol. 51, 
pp. 175-182. 
76. Interaction of Organic Phosphates with Bovine Hemoglobin. Breepoel, P M., 
Kreuzer, F. and Hazevoet, M. 1981, Pflugers Archives, Vol. 389, pp. 219-225. 
88 
 
77. Jewish General Hospital. In-patient critical values. Department of Biochemsitry.  
[Cited: August 13, 2012.] 
http://www.jgh.ca/uploads/Diagnostic%20Medicine/JGH%20Lab%20Handbook.pdf 
  
 
